{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:28:54Z","timestamp":1792146534567,"version":"4.4.0"},"reference-count":259,"publisher":"e-Century Publishing Corporation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/jiar9649","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:33:23Z","timestamp":1764732803000},"page":"4811-4844","source":"Crossref","is-referenced-by-count":4,"title":["OTU deubiquitinases in cancer pathogenesis and precision therapy"],"prefix":"10.62347","volume":"15","author":[{"given":"Shengcai","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","article-title":"Ubiquitin modifications","volume":"26","author":"Swatek","year":"2016","unstructured":"Swatek KN and Komander D. Ubiquitin modifications. Cell Res 2016; 26: 399-422.","journal-title":"Cell Res"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1042\/bst0310474","article-title":"The ubiquitin proteolytic system and pathogenesis of human diseases: a novel platform for mechanism-based drug targeting","volume":"31","author":"Ciechanover","year":"2003","unstructured":"Ciechanover A. The ubiquitin proteolytic system and pathogenesis of human diseases: a novel platform for mechanism-based drug targeting. Biochem Soc Trans 2003; 31: 474-481.","journal-title":"Biochem Soc Trans"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1042\/bse0520037","article-title":"Enzymes of ubiquitination and deubiquitination","volume":"52","author":"Neutzner","year":"2012","unstructured":"Neutzner M and Neutzner A. Enzymes of ubiquitination and deubiquitination. Essays Biochem 2012; 52: 37-50.","journal-title":"Essays Biochem"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-biochem-060815-014922","article-title":"Ubiquitin ligases: structure, function, and regulation","volume":"86","author":"Zheng","year":"2017","unstructured":"Zheng N and Shabek N. Ubiquitin ligases: structure, function, and regulation. Annu Rev Biochem 2017; 86: 129-157.","journal-title":"Annu Rev Biochem"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.7150\/ijbs.69411","article-title":"The role of ubiquitination and deubiquitination in tumor invasion and metastasis","volume":"18","author":"Han","year":"2022","unstructured":"Han S, Wang R, Zhang Y, Li X, Gan Y, Gao F, Rong P, Wang W and Li W. The role of ubiquitination and deubiquitination in tumor invasion and metastasis. Int J Biol Sci 2022; 18: 2292-2303.","journal-title":"Int J Biol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1242\/jcs.183954","article-title":"Ubiquitin chain diversity at a glance","volume":"129","author":"Akutsu","year":"2016","unstructured":"Akutsu M, Dikic I and Bremm A. Ubiquitin chain diversity at a glance. J Cell Sci 2016; 129: 875-880.","journal-title":"J Cell Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ncb3358","article-title":"The increasing complexity of the ubiquitin code","volume":"18","author":"Yau","year":"2016","unstructured":"Yau R and Rape M. The increasing complexity of the ubiquitin code. Nat Cell Biol 2016; 18: 579-586.","journal-title":"Nat Cell Biol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrm2731","article-title":"Breaking the chains: structure and function of the deubiquitinases","volume":"10","author":"Komander","year":"2009","unstructured":"Komander D, Clague MJ and Urbé S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 2009; 10: 550-563.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","unstructured":"Popovic D, Vucic D and Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med 2014; 20: 1242-1253.","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1101\/gad.339804.120","article-title":"Deubiquitinase USP20 promotes breast cancer metastasis by stabilizing SNAI2","volume":"34","author":"Li","year":"2020","unstructured":"Li W, Shen M, Jiang YZ, Zhang R, Zheng H, Wei Y, Shao ZM and Kang Y. Deubiquitinase USP20 promotes breast cancer metastasis by stabilizing SNAI2. Genes Dev 2020; 34: 1310-1315.","journal-title":"Genes Dev"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","article-title":"Breaking the chains: deubiquitylating enzyme specificity begets function","volume":"20","author":"MJ","year":"2019","unstructured":"Clague MJ, Urbé S and Komander D. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat Rev Mol Cell Biol 2019; 20: 338-352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2021.10.027","article-title":"Deubiquitinases: from mechanisms to their inhibition by small molecules","volume":"82","author":"SM","year":"2022","unstructured":"Lange SM, Armstrong LA and Kulathu Y. Deubiquitinases: from mechanisms to their inhibition by small molecules. Mol Cell 2022; 82: 15-29.","journal-title":"Mol Cell"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s11684-019-0734-4","article-title":"The function and regulation of OTU deubiquitinases","volume":"14","author":"Du","year":"2020","unstructured":"Du J, Fu L, Sui Y and Zhang L. The function and regulation of OTU deubiquitinases. Front Med 2020; 14: 542-563.","journal-title":"Front Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2013.05.046","article-title":"OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis","volume":"154","author":"Mevissen","year":"2013","unstructured":"Mevissen TE, Hospenthal MK, Geurink PP, Elliott PR, Akutsu M, Arnaudo N, Ekkebus R, Kulathu Y, Wauer T, El Oualid F, Freund SM, Ovaa H and Komander D. OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell 2013; 154: 169-184.","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"920287","DOI":"10.3389\/fonc.2022.920287","article-title":"Research Progress of DUB Enzyme in Hepatocellular Carcinoma","volume":"12","author":"Zhao","year":"2022","unstructured":"Zhao J, Guo J, Wang Y, Ma Q, Shi Y, Cheng F, Lu Q, Fu W, Ouyang G, Zhang J, Xu Q and Hu X. Research Progress of DUB Enzyme in Hepatocellular Carcinoma. Front Oncol 2022; 12: 920287.","journal-title":"Front Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2002874","DOI":"10.1002\/advs.202002874","article-title":"OTUD1 Activates caspase-independent and caspase-dependent apoptosis by promoting AIF nuclear translocation and MCL1 degradation","volume":"8","author":"Luo","year":"2021","unstructured":"Luo Q, Wu X, Zhao P, Nan Y, Chang W, Zhu X, Su D and Liu Z. OTUD1 Activates caspase-independent and caspase-dependent apoptosis by promoting AIF nuclear translocation and MCL1 degradation. Adv Sci (Weinh) 2021; 8: 2002874.","journal-title":"Adv Sci (Weinh)"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/sj.embor.7400201","article-title":"Crystal structure of human otubain 2","volume":"5","author":"Nanao","year":"2004","unstructured":"Nanao MH, Tcherniuk SO, Chroboczek J, Dideberg O, Dessen A and Balakirev MY. Crystal structure of human otubain 2. EMBO Rep 2004; 5: 783-788.","journal-title":"EMBO Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.chembiol.2016.04.001","article-title":"Novel diubiquitin probes expand the chemical toolkit to study DUBs","volume":"23","author":"Kulathu","year":"2016","unstructured":"Kulathu Y. Novel diubiquitin probes expand the chemical toolkit to study DUBs. Cell Chem Biol 2016; 23: 432-434.","journal-title":"Cell Chem Biol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","unstructured":"Komander D and Rape M. The ubiquitin code. Annu Rev Biochem 2012; 81: 203-229.","journal-title":"Annu Rev Biochem"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-020-00245-6","article-title":"Beyond K48 and K63: non-canonical protein ubiquitination","volume":"26","author":"Tracz","year":"2021","unstructured":"Tracz M and Bialek W. Beyond K48 and K63: non-canonical protein ubiquitination. Cell Mol Biol Lett 2021; 26: 1.","journal-title":"Cell Mol Biol Lett"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Saldana M, VanderVorst K, Berg AL, Lee H and Carraway KL. Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer. Endocr Relat Cancer 2019; 26: R1-R14.","DOI":"10.1530\/ERC-18-0264"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.molcel.2012.01.011","article-title":"OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function","volume":"45","author":"Juang","year":"2012","unstructured":"Juang YC, Landry MC, Sanches M, Vittal V, Leung CC, Ceccarelli DF, Mateo AR, Pruneda JN, Mao DY, Szilard RK, Orlicky S, Munro M, Brzovic PS, Klevit RE, Sicheri F and Durocher D. OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function. Mol Cell 2012; 45: 384-397.","journal-title":"Mol Cell"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nature09297","article-title":"Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1","volume":"466","author":"Nakada","year":"2010","unstructured":"Nakada S, Tai I, Panier S, Al-Hakim A, Iemura S, Juang YC, O’Donnell L, Kumakubo A, Munro M, Sicheri F, Gingras AC, Natsume T, Suda T and Durocher D. Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1. Nature 2010; 466: 941-946.","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s13402-023-00913-7","article-title":"OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination","volume":"47","author":"Peng","year":"2024","unstructured":"Peng L, Wu T, Liu Y, Zhao D, He W and Yuan Y. OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination. Cell Oncol (Dordr) 2024; 47: 987-1004.","journal-title":"Cell Oncol (Dordr)"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1038\/s41388-022-02507-3","article-title":"OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer","volume":"41","author":"Yan","year":"2022","unstructured":"Yan C, Yang H, Su P, Li X, Li Z, Wang D, Zang Y, Wang T, Liu Z, Bao Z, Dong S, Zhuang T, Zhu J and Ding Y. OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer. Oncogene 2022; 41: 5186-5198.","journal-title":"Oncogene"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1158\/0008-5472.CAN-18-3037","article-title":"The deubiquitylase OTUB1 mediates ferroptosis via stabilization of SLC7A11","volume":"79","author":"Liu","year":"2019","unstructured":"Liu T, Jiang L, Tavana O and Gu W. The deubiquitylase OTUB1 mediates ferroptosis via stabilization of SLC7A11. Cancer Res 2019; 79: 1913-1924.","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","article-title":"CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1","volume":"42","author":"Li","year":"2023","unstructured":"Li D, Wang Y, Dong C, Chen T, Dong A, Ren J, Li W, Shu G, Yang J, Shen W, Qin L, Hu L and Zhou J. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene 2023; 42: 83-98.","journal-title":"Oncogene"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Liao Y, Yang M, Wang K, Wang Y, Zhong B and Jiang N. Deubiquitinating enzyme OTUB1 in immunity and cancer: good player or bad actor? Cancer Lett 2022; 526: 248-258.","DOI":"10.1016\/j.canlet.2021.12.002"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41418-020-00700-z","article-title":"Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1","volume":"28","author":"Zhu","year":"2021","unstructured":"Zhu D, Xu R, Huang X, Tang Z, Tian Y, Zhang J and Zheng X. Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1. Cell Death Differ 2021; 28: 1773-1789.","journal-title":"Cell Death Differ"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Wang X, Mulas F, Yi W, Brunn A, Nishanth G, Just S, Waisman A, Brück W, Deckert M and Schlüter D. OTUB1 inhibits CNS autoimmunity by preventing IFN-γ-induced hyperactivation of astrocytes. EMBO J 2019; 38: e100947.","DOI":"10.15252\/embj.2018100947"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Li YJ, Chen CY, Kuo YS, Huang YW, Kuo RL, Chang LK, Yang JH, Lai CH, Shih SR and Chiu YF. OTUB1 contributes to the stability and function of influenza A virus NS2. PLoS Pathog 2024; 20: e1012279.","DOI":"10.1371\/journal.ppat.1012279"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/febs.15035","article-title":"Scavenger receptor A impairs interferon response to HBV infection by limiting TRAF3 ubiquitination through recruiting OTUB1","volume":"287","author":"Xie","year":"2020","unstructured":"Xie M, Yin Y, Chen L, Yin A, Liu Y, Liu Y, Dong L, Lai Q, Zhou J, Zhang L, Xu M, Chen Z and Zuo D. Scavenger receptor A impairs interferon response to HBV infection by limiting TRAF3 ubiquitination through recruiting OTUB1. FEBS J 2020; 287: 310-324.","journal-title":"FEBS J"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1074\/jbc.RA120.013073","article-title":"Activation and selectivity of OTUB-1 and OTUB-2 deubiquitinylases","volume":"295","author":"Sivakumar","year":"2020","unstructured":"Sivakumar D, Kumar V, Naumann M and Stein M. Activation and selectivity of OTUB-1 and OTUB-2 deubiquitinylases. J Biol Chem 2020; 295: 6972-6982.","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Zhang Z, Du J, Wang S, Shao L, Jin K, Li F, Wei B, Ding W, Fu P, van Dam H, Wang A, Jin J, Ding C, Yang B, Zheng M, Feng XH, Guan KL and Zhang L. OTUB2 promotes cancer metastasis via hippo-independent activation of YAP and TAZ. Mol Cell 2019; 73: 7-21, e7.","DOI":"10.1016\/j.molcel.2018.10.030"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1038\/s41401-021-00754-w","article-title":"Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation","volume":"42","author":"ZN","year":"2021","unstructured":"Lu ZN, Niu WX, Zhang N, Ge MX, Bao YY, Ren Y, Guo XL and He HW. Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation. Acta Pharmacol Sin 2021; 42: 1808-1820.","journal-title":"Acta Pharmacol Sin"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/CMAR.S184781","article-title":"miR-29a-3p inhibits growth, proliferation, and invasion of papillary thyroid carcinoma by suppressing NF-κB signaling via direct targeting of OTUB2","volume":"11","author":"Ma","year":"2019","unstructured":"Ma Y and Sun Y. miR-29a-3p inhibits growth, proliferation, and invasion of papillary thyroid carcinoma by suppressing NF-κB signaling via direct targeting of OTUB2. Cancer Manag Res 2019; 11: 13-23.","journal-title":"Cancer Manag Res"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/kjm2.12187","article-title":"Knockdown of otubain 2 inhibits liver cancer cell growth by suppressing NF-κB signaling","volume":"36","author":"ZL","year":"2020","unstructured":"Gu ZL, Huang J and Zhen LL. Knockdown of otubain 2 inhibits liver cancer cell growth by suppressing NF-κB signaling. Kaohsiung J Med Sci 2020; 36: 399-404.","journal-title":"Kaohsiung J Med Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7150\/thno.29545","article-title":"OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT\/mTOR signaling pathway in non-small cell lung cancer","volume":"9","author":"Li","year":"2019","unstructured":"Li J, Cheng D, Zhu M, Yu H, Pan Z, Liu L, Geng Q, Pan H, Yan M and Yao M. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT\/mTOR signaling pathway in non-small cell lung cancer. Theranostics 2019; 9: 179-195.","journal-title":"Theranostics"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.molcel.2014.01.030","article-title":"Fine-tuning of DNA damage-dependent ubiquitination by OTUB2 supports the DNA repair pathway choice","volume":"53","author":"Kato","year":"2014","unstructured":"Kato K, Nakajima K, Ui A, Muto-Terao Y, Ogiwara H and Nakada S. Fine-tuning of DNA damage-dependent ubiquitination by OTUB2 supports the DNA repair pathway choice. Mol Cell 2014; 53: 617-630.","journal-title":"Mol Cell"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1074\/jbc.M109.074971","article-title":"Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6","volume":"285","author":"Li","year":"2010","unstructured":"Li S, Zheng H, Mao AP, Zhong B, Li Y, Liu Y, Gao Y, Ran Y, Tien P and Shu HB. Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. J Biol Chem 2010; 285: 4291-4297.","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41467-023-44466-7","article-title":"Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1","volume":"15","author":"Ren","year":"2024","unstructured":"Ren W, Xu Z, Chang Y, Ju F, Wu H, Liang Z, Zhao M, Wang N, Lin Y, Xu C, Chen S, Rao Y, Lin C, Yang J, Liu P, Zhang J, Huang C and Xia N. Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1. Nat Commun 2024; 15: 9.","journal-title":"Nat Commun"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41388-021-02071-2","article-title":"Deubiquitinase OTUB2 exacerbates the progression of colorectal cancer by promoting PKM2 activity and glycolysis","volume":"41","author":"Yu","year":"2022","unstructured":"Yu S, Zang W, Qiu Y, Liao L and Zheng X. Deubiquitinase OTUB2 exacerbates the progression of colorectal cancer by promoting PKM2 activity and glycolysis. Oncogene 2022; 41: 46-56.","journal-title":"Oncogene"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/cbin.11950","article-title":"OTUB2 promotes the progression of endometrial cancer by regulating the PKM2-mediated PI3K\/AKT signaling pathway","volume":"47","author":"Zhang","year":"2023","unstructured":"Zhang Q, Zhang J, Yao A, Tian X, Han Z, Yuan Y, Tao K and Yang X. OTUB2 promotes the progression of endometrial cancer by regulating the PKM2-mediated PI3K\/AKT signaling pathway. Cell Biol Int 2023; 47: 428-438.","journal-title":"Cell Biol Int"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Wang S, Hou P, Pan W, He W, He DC, Wang H and He H. DDIT3 targets innate immunity via the DDIT3-OTUD1-MAVS pathway to promote bovine viral diarrhea virus replication. J Virol 2021; 95: e02351-20.","DOI":"10.1128\/JVI.02351-20"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellsig.2017.02.011","article-title":"Ovarian tumor domain-containing protein 1 deubiquitinates and stabilizes p53","volume":"33","author":"Piao","year":"2017","unstructured":"Piao S, Pei HZ, Huang B and Baek SH. Ovarian tumor domain-containing protein 1 deubiquitinates and stabilizes p53. Cell Signal 2017; 33: 22-29.","journal-title":"Cell Signal"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Song J, Liu T, Yin Y, Zhao W, Lin Z, Yin Y, Lu D and You F. The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity. EMBO Rep 2021; 22: e51162.","DOI":"10.15252\/embr.202051162"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41420-022-01119-w","article-title":"Deubiquitylase OTUD1 confers Erlotinib sensitivity in non-small cell lung cancer through inhibition of nuclear translocation of YAP1","volume":"8","author":"Liu","year":"2022","unstructured":"Liu H, Zhong L, Lu Y, Liu X, Wei J, Ding Y, Huang H, Nie Q and Liao X. Deubiquitylase OTUD1 confers Erlotinib sensitivity in non-small cell lung cancer through inhibition of nuclear translocation of YAP1. Cell Death Discov 2022; 8: 403.","journal-title":"Cell Death Discov"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Zhang L, Liu J, Qian L, Feng Q, Wang X, Yuan Y, Zuo Y, Cheng Q, Miao Y, Guo T, Zheng X and Zheng H. Induction of OTUD1 by RNA viruses potently inhibits innate immune responses by promoting degradation of the MAVS\/TRAF3\/TRAF6 signalosome. PLoS Pathog 2018; 14: e1007067.","DOI":"10.1371\/journal.ppat.1007067"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.3892\/ol.2019.10883","article-title":"Distinct expression and prognostic value of OTU domain-containing proteins in non-small-cell lung cancer","volume":"18","author":"Deng","year":"2019","unstructured":"Deng J, Hou G, Fang Z, Liu J and Lv XD. Distinct expression and prognostic value of OTU domain-containing proteins in non-small-cell lung cancer. Oncol Lett 2019; 18: 5417-5427.","journal-title":"Oncol Lett"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.molcel.2009.09.016","article-title":"The otubain YOD1 is a deubiquitinating enzyme that associates with p97 to facilitate protein dislocation from the ER","volume":"36","author":"Ernst","year":"2009","unstructured":"Ernst R, Mueller B, Ploegh HL and Schlieker C. The otubain YOD1 is a deubiquitinating enzyme that associates with p97 to facilitate protein dislocation from the ER. Mol Cell 2009; 36: 28-38.","journal-title":"Mol Cell"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/sj.embor.embor824","article-title":"Otubains: a new family of cysteine proteases in the ubiquitin pathway","volume":"4","author":"Balakirev","year":"2003","unstructured":"Balakirev MY, Tcherniuk SO, Jaquinod M and Chroboczek J. Otubains: a new family of cysteine proteases in the ubiquitin pathway. EMBO Rep 2003; 4: 517-522.","journal-title":"EMBO Rep"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Schimmack G, Schorpp K, Kutzner K, Gehring T, Brenke JK, Hadian K and Krappmann D. YOD1\/TRAF6 association balances p62-dependent IL-1 signaling to NF-κB. Elife 2017; 6: e22416.","DOI":"10.7554\/eLife.22416"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13046-023-02781-3","article-title":"Deubiquitylase YOD1 regulates CDK1 stability and drives triple-negative breast cancer tumorigenesis","volume":"42","author":"Han","year":"2023","unstructured":"Han Z, Jia Q, Zhang J, Chen M, Wang L, Tong K, He W, Zhang Y, Zhu W, Qin J, Wang T, Liu T, Ma Y, Chen Y, Zha S and Zhang C. Deubiquitylase YOD1 regulates CDK1 stability and drives triple-negative breast cancer tumorigenesis. J Exp Clin Cancer Res 2023; 42: 228.","journal-title":"J Exp Clin Cancer Res"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"135","DOI":"10.15252\/embj.201695148","article-title":"VCP\/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy","volume":"36","author":"Papadopoulos","year":"2017","unstructured":"Papadopoulos C, Kirchner P, Bug M, Grum D, Koerver L, Schulze N, Poehler R, Dressler A, Fengler S, Arhzaouy K, Lux V, Ehrmann M, Weihl CC and Meyer H. VCP\/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy. EMBO J 2017; 36: 135-150.","journal-title":"EMBO J"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1182\/blood-2012-08-447409","article-title":"A catalytically inactive mutant of the deubiquitylase YOD-1 enhances antigen cross-presentation","volume":"121","author":"Sehrawat","year":"2013","unstructured":"Sehrawat S, Koenig PA, Kirak O, Schlieker C, Fankhauser M and Ploegh HL. A catalytically inactive mutant of the deubiquitylase YOD-1 enhances antigen cross-presentation. Blood 2013; 121: 1145-1156.","journal-title":"Blood"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0962-8924(02)02269-9","article-title":"From UBA to UBX: new words in the ubiquitin vocabulary","volume":"12","author":"Buchberger","year":"2002","unstructured":"Buchberger A. From UBA to UBX: new words in the ubiquitin vocabulary. Trends in Cell Biology 2002; 12: 216-221.","journal-title":"Trends in Cell Biology"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"194901","DOI":"10.1016\/j.bbagrm.2022.194901","article-title":"OTUD3: a Lys6 and Lys63 specific deubiquitinase in early vertebrate development","volume":"1866","author":"Job","year":"2023","unstructured":"Job F, Mai C, Villavicencio-Lorini P, Herfurth J, Neuhaus H, Hoffmann K, Pfirrmann T and Hollemann T. OTUD3: a Lys6 and Lys63 specific deubiquitinase in early vertebrate development. Biochim Biophys Acta Gene Regul Mech 2023; 1866: 194901.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Zhang Z, Fang X, Wu X, Ling L, Chu F, Li J, Wang S, Zang J, Zhang B, Ye S, Zhang L, Yang B, Lin S, Huang H, Wang A and Zhou F. Acetylation-dependent deubiquitinase OTUD3 controls MAVS activation in innate antiviral immunity. Mol Cell 2020; 79: 304-319.e7.","DOI":"10.1016\/j.molcel.2020.06.020"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Zhou N, Qi H, Liu J, Zhang G, Liu J, Liu N, Zhu M, Zhao X, Song C, Zhou Z, Gong J, Li R, Bai X, Jin Y, Song Y and Yin Y. Deubiquitinase OTUD3 regulates metabolism homeostasis in response to nutritional stresses. Cell Metab 2022; 34: 1023-1041, e8.","DOI":"10.1016\/j.cmet.2022.05.005"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41419-022-04704-0","article-title":"Deubiquitylase OTUD3 prevents Parkinson’s disease through stabilizing iron regulatory protein 2","volume":"13","author":"Jia","year":"2022","unstructured":"Jia F, Li H, Jiao Q, Li C, Fu L, Cui C, Jiang H and Zhang L. Deubiquitylase OTUD3 prevents Parkinson’s disease through stabilizing iron regulatory protein 2. Cell Death Dis 2022; 13: 418.","journal-title":"Cell Death Dis"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Louis M, Hofmann K and Broemer M. Evolutionary loss of activity in De-ubiquitylating enzymes of the OTU family. PLoS One 2015; 10: e0143227.","DOI":"10.1371\/journal.pone.0143227"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Zhao Y, Mudge MC, Soll JM, Rodrigues RB, Byrum AK, Schwarzkopf EA, Bradstreet TR, Gygi SP, Edelson BT and Mosammaparast N. OTUD4 is a phospho-activated K63 deubiquitinase that regulates MyD88-dependent signaling. Mol Cell 2018; 69: 505-516, e5.","DOI":"10.1016\/j.molcel.2018.01.009"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41422-018-0107-6","article-title":"Induction of OTUD4 by viral infection promotes antiviral responses through deubiquitinating and stabilizing MAVS","volume":"29","author":"Liuyu","year":"2019","unstructured":"Liuyu T, Yu K, Ye L, Zhang Z, Zhang M, Ren Y, Cai Z, Zhu Q, Lin D and Zhong B. Induction of OTUD4 by viral infection promotes antiviral responses through deubiquitinating and stabilizing MAVS. Cell Res 2019; 29: 67-79.","journal-title":"Cell Res"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.15252\/embj.201490497","article-title":"Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase","volume":"34","author":"Zhao","year":"2015","unstructured":"Zhao Y, Majid MC, Soll JM, Brickner JR, Dango S and Mosammaparast N. Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase. EMBO J 2015; 34: 1687-1703.","journal-title":"EMBO J"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/nar\/gky1219","article-title":"The OTUD5-UBR5 complex regulates FACT-mediated transcription at damaged chromatin","volume":"47","author":"de Vivo","year":"2019","unstructured":"de Vivo A, Sanchez A, Yegres J, Kim J, Emly S and Kee Y. The OTUD5-UBR5 complex regulates FACT-mediated transcription at damaged chromatin. Nucleic Acids Res 2019; 47: 729-746.","journal-title":"Nucleic Acids Res"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1038\/s41467-020-17926-7","article-title":"OTUD5 cooperates with TRIM25 in transcriptional regulation and tumor progression via deubiquitination activity","volume":"11","author":"Li","year":"2020","unstructured":"Li F, Sun Q, Liu K, Zhang L, Lin N, You K, Liu M, Kon N, Tian F, Mao Z, Li T, Tong T, Qin J, Gu W, Li D and Zhao W. OTUD5 cooperates with TRIM25 in transcriptional regulation and tumor progression via deubiquitination activity. Nat Commun 2020; 11: 4184.","journal-title":"Nat Commun"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.canlet.2014.12.005","article-title":"Deubiquitinase OTUD5 mediates the sequential activation of PDCD5 and p53 in response to genotoxic stress","volume":"357","author":"Park","year":"2015","unstructured":"Park SY, Choi HK, Choi Y, Kwak S, Choi KC and Yoon HG. Deubiquitinase OTUD5 mediates the sequential activation of PDCD5 and p53 in response to genotoxic stress. Cancer Lett 2015; 357: 419-427.","journal-title":"Cancer Lett"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Beck DB, Basar MA, Asmar AJ, Thompson JJ, Oda H, Uehara DT, Saida K, Pajusalu S, Talvik I, D’Souza P, Bodurtha J, Mu W, Barañano KW, Miyake N, Wang R, Kempers M, Tamada T, Nishimura Y, Okada S, Kosho T, Dale R, Mitra A and Macnamara E; Undiagnosed Diseases Network; Matsumoto N, Inazawa J, Walkiewicz M, Õunap K, Tifft CJ, Aksentijevich I, Kastner DL, Rocha PP and Werner A. Linkage-specific deubiquitylation by OTUD5 defines an embryonic pathway intolerant to genomic variation. Sci Adv 2021; 7: eabe2116.","DOI":"10.1126\/sciadv.abe2116"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","article-title":"Mechanisms of deubiquitinase specificity and regulation","volume":"86","author":"Mevissen","year":"2017","unstructured":"Mevissen TET and Komander D. Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem 2017; 86: 159-192.","journal-title":"Annu Rev Biochem"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nsmb.2206","article-title":"Phosphorylation-dependent activity of the deubiquitinase DUBA","volume":"19","author":"Huang","year":"2012","unstructured":"Huang OW, Ma X, Yin J, Flinders J, Maurer T, Kayagaki N, Phung Q, Bosanac I, Arnott D, Dixit VM, Hymowitz SG, Starovasnik MA and Cochran AG. Phosphorylation-dependent activity of the deubiquitinase DUBA. Nat Struct Mol Biol 2012; 19: 171-175.","journal-title":"Nat Struct Mol Biol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1074\/mcp.RA120.002290","article-title":"Proteome-wide analysis reveals substrates of E3 ligase RNF146 targeted for degradation","volume":"19","author":"Nie","year":"2020","unstructured":"Nie L, Wang C, Li N, Feng X, Lee N, Su D, Tang M, Yao F and Chen J. Proteome-wide analysis reveals substrates of E3 ligase RNF146 targeted for degradation. Mol Cell Proteomics 2020; 19: 2015-2030.","journal-title":"Mol Cell Proteomics"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1126\/science.1145918","article-title":"DUBA: a deubiquitinase that regulates type I interferon production","volume":"318","author":"Kayagaki","year":"2007","unstructured":"Kayagaki N, Phung Q, Chan S, Chaudhari R, Quan C, O’Rourke KM, Eby M, Pietras E, Cheng G, Bazan JF, Zhang Z, Arnott D and Dixit VM. DUBA: a deubiquitinase that regulates type I interferon production. Science 2007; 318: 1628-1632.","journal-title":"Science"},{"key":"ref72","unstructured":"Asselta R, Paraboschi EM, Gerussi A, Cordell HJ, Mells GF, Sandford RN, Jones DE, Nakamura M, Ueno K, Hitomi Y, Kawashima M, Nishida N, Tokunaga K, Nagasaki M, Tanaka A, Tang R, Li Z, Shi Y, Liu X, Xiong M, Hirschfield G and Siminovitch KA; Canadian-US PBC Consortium; Italian PBC Genetics Study Group; UK-PBC Consortium; Japan PBC-GWAS Consortium; Carbone M, Cardamone G, Duga S, Gershwin ME, Seldin MF and Invernizzi P. X chromosome contribution to the genetic architecture of primary biliary cholangitis. Gastroenterology 2021; 160: 2483-2495, e26."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/ecco-jcc\/jjab121","article-title":"The deubiquitinating enzyme OTUD5 sustains inflammatory cytokine response in inflammatory bowel disease","volume":"16","author":"Dinallo","year":"2021","unstructured":"Dinallo V, Di Fusco D, Di Grazia A, Laudisi F, Troncone E, Di Maggio G, Franzè E, Marafini I, Colantoni A, Ortenzi A, Stolfi C, Di Daniele N, Monteleone I and Monteleone G. The deubiquitinating enzyme OTUD5 sustains inflammatory cytokine response in inflammatory bowel disease. J Crohns Colitis 2021; 16: 122-132.","journal-title":"J Crohns Colitis"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Liu L, Pang J, Qin D, Li R, Zou D, Chi K, Wu W, Rui H, Yu H, Zhu W, Liu K, Wu X, Wang J, Xu P, Song X, Cao Y, Wang J, Xu F, Xue L and Chen Y. Deubiquitinase OTUD5 as a novel protector against 4-HNE-triggered ferroptosis in myocardial ischemia\/reperfusion injury. Adv Sci (Weinh) 2023; 10: e2301852.","DOI":"10.1002\/advs.202301852"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"8393","DOI":"10.1038\/s41467-023-44228-5","article-title":"Autophagy of OTUD5 destabilizes GPX4 to confer ferroptosis-dependent kidney injury","volume":"14","author":"Chu","year":"2023","unstructured":"Chu LK, Cao X, Wan L, Diao Q, Zhu Y, Kan Y, Ye LL, Mao YM, Dong XQ, Xiong QW, Fu MC, Zhang T, Zhou HT, Cai SZ, Ma ZR, Hsu SW, Wu R, Chen CH, Yan XM and Liu J. Autophagy of OTUD5 destabilizes GPX4 to confer ferroptosis-dependent kidney injury. Nat Commun 2023; 14: 8393.","journal-title":"Nat Commun"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1038\/s41388-023-02744-0","article-title":"The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis","volume":"42","author":"Wang","year":"2023","unstructured":"Wang Z, Ouyang L, Liu N, Li T, Yan B, Mao C, Xiao D, Gan B, Liu S and Tao Y. The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis. Oncogene 2023; 42: 2688-2700.","journal-title":"Oncogene"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13062-024-00475-0","article-title":"OTUD5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing SLC38A1","volume":"19","author":"Yang","year":"2024","unstructured":"Yang Y, Jia S, Zhu N, Xiao X, Ma Y, Tu K, Guo Y and Xu Q. OTUD5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing SLC38A1. Biol Direct 2024; 19: 31.","journal-title":"Biol Direct"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41418-023-01148-7","article-title":"Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3","volume":"30","author":"Liu","year":"2023","unstructured":"Liu X, Fang Y, Lv X, Hu C, Chen G, Zhang L, Jin B, Huang L, Luo W, Liang G and Wang Y. Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3. Cell Death Differ 2023; 30: 1457-1471.","journal-title":"Cell Death Differ"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"167061","DOI":"10.1016\/j.bbadis.2024.167061","article-title":"Deubiquitinase OTUD6a drives cardiac inflammation and hypertrophy by deubiquitination of STING","volume":"1870","author":"Fang","year":"2024","unstructured":"Fang Z, Han J, Lin L, Ye B, Qu X, Zhang Y, Zhao Y, Xu D, Lin W, Shen S, Min J, Wu G, Huang Z and Liang G. Deubiquitinase OTUD6a drives cardiac inflammation and hypertrophy by deubiquitination of STING. Biochim Biophys Acta Mol Basis Dis 2024; 1870: 167061.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3390\/v15081761","article-title":"Deubiquitinase OTUD6A regulates innate immune response via targeting UBC13","volume":"15","author":"Li","year":"2023","unstructured":"Li Z, Li G, Li Y, Luo Y, Jiang Y, Zhang Z, Zhou Z, Liu S, Wu C and You F. Deubiquitinase OTUD6A regulates innate immune response via targeting UBC13. Viruses 2023; 15: 1761.","journal-title":"Viruses"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/s41418-022-00960-x","article-title":"Prostate-specific oncogene OTUD6A promotes prostatic tumorigenesis via deubiquitinating and stabilizing c-Myc","volume":"29","author":"Peng","year":"2022","unstructured":"Peng Y, Liu J, Wang Z, Cui C, Zhang T, Zhang S, Gao P, Hou Z, Liu H, Guo J, Zhang J, Wen Y, Wei W, Zhang L, Liu J and Long J. Prostate-specific oncogene OTUD6A promotes prostatic tumorigenesis via deubiquitinating and stabilizing c-Myc. Cell Death Differ 2022; 29: 1730-1743.","journal-title":"Cell Death Differ"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s42003-022-03133-1","article-title":"OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR","volume":"5","author":"Fu","year":"2022","unstructured":"Fu X, Zhao J, Yu G, Zhang X, Sun J, Li L, Yin J, Niu Y, Ren S, Zhu Y, Xu B and Huang L. OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR. Commun Biol 2022; 5: 182.","journal-title":"Commun Biol"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/s41418-022-01036-6","article-title":"Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy","volume":"29","author":"Zhao","year":"2022","unstructured":"Zhao Y, Huang X, Zhu D, Wei M, Luo J, Yu S, Tian Y and Zheng X. Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy. Cell Death Differ 2022; 29: 2531-2544.","journal-title":"Cell Death Differ"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1002\/1878-0261.12825","article-title":"Deubiquitinase OTUD6A promotes proliferation of cancer cells via regulating Drp1 stability and mitochondrial fission","volume":"14","author":"Shi","year":"2020","unstructured":"Shi L, Liu J, Peng Y, Zhang J, Dai X, Zhang S, Wang Y, Liu J and Long J. Deubiquitinase OTUD6A promotes proliferation of cancer cells via regulating Drp1 stability and mitochondrial fission. Mol Oncol 2020; 14: 3169-3183.","journal-title":"Mol Oncol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12943-024-01996-y","article-title":"Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance","volume":"23","author":"Cui","year":"2024","unstructured":"Cui J, Liu X, Shang Q, Sun S, Chen S, Dong J, Zhu Y, Liu L, Xia Y, Wang Y, Xiang L, Fan B, Zhan J, Zhou Y, Chen P, Zhao R, Liu X, Xing N, Wu D, Shi B and Zou Y. Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance. Mol Cancer 2024; 23: 86.","journal-title":"Mol Cancer"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1158\/1541-7786.MCR-16-0281-T","article-title":"Deubiquitinase OTUD6B isoforms are important regulators of growth and proliferation","volume":"15","author":"Sobol","year":"2017","unstructured":"Sobol A, Askonas C, Alani S, Weber MJ, Ananthanarayanan V, Osipo C and Bocchetta M. Deubiquitinase OTUD6B isoforms are important regulators of growth and proliferation. Mol Cancer Res 2017; 15: 117-127.","journal-title":"Mol Cancer Res"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13062-024-00489-8","article-title":"The deubiquitinating protein OTUD6B promotes lung adenocarcinoma progression by stabilizing RIPK1","volume":"19","author":"Yang","year":"2024","unstructured":"Yang M, Wei Y, He X and Xia C. The deubiquitinating protein OTUD6B promotes lung adenocarcinoma progression by stabilizing RIPK1. Biol Direct 2024; 19: 46.","journal-title":"Biol Direct"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Paulmann C, Spallek R, Karpiuk O, Heider M, Schäffer I, Zecha J, Klaeger S, Walzik M, Öllinger R, Engleitner T, Wirth M, Keller U, Krönke J, Rudelius M, Kossatz S, Rad R, Kuster B and Bassermann F. The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myeloma. EMBO J 2022; 41: e110871.","DOI":"10.15252\/embj.2022110871"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbrc.2023.08.036","article-title":"MCTS1 enhances the proliferation of laryngeal squamous cell carcinoma via promoting OTUD6B-1 mediated LIN28B deubiquitination","volume":"678","author":"Ma","year":"2023","unstructured":"Ma B, Wei X, Zhou S and Yang M. MCTS1 enhances the proliferation of laryngeal squamous cell carcinoma via promoting OTUD6B-1 mediated LIN28B deubiquitination. Biochem Biophys Res Commun 2023; 678: 128-134.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1902040","DOI":"10.1002\/advs.201902040","article-title":"Deubiquitylase OTUD6B governs pVHL stability in an enzyme-independent manner and suppresses hepatocellular carcinoma metastasis","volume":"7","author":"Liu","year":"2020","unstructured":"Liu X, Zhang X, Peng Z, Li C, Wang Z, Wang C, Deng Z, Wu B, Cui Y, Wang Z, Cui CP, Zheng M and Zhang L. Deubiquitylase OTUD6B governs pVHL stability in an enzyme-independent manner and suppresses hepatocellular carcinoma metastasis. Adv Sci (Weinh) 2020; 7: 1902040.","journal-title":"Adv Sci (Weinh)"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41419-021-04135-3","article-title":"Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma","volume":"13","author":"Guo","year":"2022","unstructured":"Guo K, Wei Y, Wang Z, Zhang X, Zhang X, Liu X, Wu W, Wu Z, Zhang L and Cui CP. Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma. Cell Death Dis 2022; 13: 97.","journal-title":"Cell Death Dis"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/ajmg.a.63179","article-title":"Long-term outcomes in ALG13-Congenital Disorder of Glycosylation","volume":"191","author":"Shah","year":"2023","unstructured":"Shah R, Johnsen C, Pletcher BA, Edmondson AC, Kozicz T and Morava E. Long-term outcomes in ALG13-Congenital Disorder of Glycosylation. Am J Med Genet A 2023; 191: 1626-1631.","journal-title":"Am J Med Genet A"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/jimd.12290","article-title":"Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: clinical description, biomarker status, biochemical analysis, and treatment suggestions","volume":"43","author":"BG","year":"2020","unstructured":"Ng BG, Eklund EA, Shiryaev SA, Dong YY, Abbott MA, Asteggiano C, Bamshad MJ, Barr E, Bernstein JA, Chelakkadan S, Christodoulou J, Chung WK, Ciliberto MA, Cousin J, Gardiner F, Ghosh S, Graf WD, Grunewald S, Hammond K, Hauser NS, Hoganson GE, Houck KM, Kohler JN, Morava E, Larson AA, Liu P, Madathil S, McCormack C, Meeks NJL, Miller R, Monaghan KG, Nickerson DA, Palculict TB, Papazoglu GM, Pletcher BA, Scheffer IE, Schenone AB, Schnur RE, Si Y, Rowe LJ, Serrano Russi AH, Russo RS, Thabet F, Tuite A, Villanueva MM, Wang RY, Webster RI, Wilson D and Zalan A; Undiagnosed Diseases Network, University of Washington Center for Mendelian Genomics (UW-CMG); Wolfe LA, Rosenfeld JA, Rhodes L and Freeze HH. Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: clinical description, biomarker status, biochemical analysis, and treatment suggestions. J Inherit Metab Dis 2020; 43: 1333-1348.","journal-title":"J Inherit Metab Dis"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11064-024-04300-y","article-title":"ALG13-related epilepsy: current insights and future research directions","volume":"50","author":"Gao","year":"2024","unstructured":"Gao P, Chen H, Sun Y, Qian X, Sun T, Fan Y and Zhang J. ALG13-related epilepsy: current insights and future research directions. Neurochem Res 2024; 50: 60.","journal-title":"Neurochem Res"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1042\/BJ20071399","article-title":"Structure of the A20 OTU domain and mechanistic insights into deubiquitination","volume":"409","author":"Komander","year":"2008","unstructured":"Komander D and Barford D. Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem J 2008; 409: 77-85.","journal-title":"Biochem J"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3389\/fimmu.2019.02665","article-title":"T regulatory cells from non-obese diabetic mice show low responsiveness to IL-2 stimulation and exhibit differential expression of anergy-related and ubiquitination factors","volume":"10","author":"Godoy","year":"2019","unstructured":"Godoy GJ, Olivera C, Paira DA, Salazar FC, Ana Y, Stempin CC, Motrich RD and Rivero VE. T regulatory cells from non-obese diabetic mice show low responsiveness to IL-2 stimulation and exhibit differential expression of anergy-related and ubiquitination factors. Front Immunol 2019; 10: 2665.","journal-title":"Front Immunol"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nature02794","article-title":"De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling","volume":"430","author":"IE","year":"2004","unstructured":"Wertz IE, O’Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV and Dixit VM. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004; 430: 694-699.","journal-title":"Nature"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.molcel.2010.10.009","article-title":"Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling","volume":"40","author":"Bosanac","year":"2010","unstructured":"Bosanac I, Wertz IE, Pan B, Yu C, Kusam S, Lam C, Phu L, Phung Q, Maurer B, Arnott D, Kirkpatrick DS, Dixit VM and Hymowitz SG. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling. Mol Cell 2010; 40: 548-557.","journal-title":"Mol Cell"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1038\/emboj.2012.241","article-title":"Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation","volume":"31","author":"Tokunaga","year":"2012","unstructured":"Tokunaga F, Nishimasu H, Ishitani R, Goto E, Noguchi T, Mio K, Kamei K, Ma A, Iwai K and Nureki O. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation. EMBO J 2012; 31: 3856-3870.","journal-title":"EMBO J"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1038\/emboj.2012.240","article-title":"A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7","volume":"31","author":"Verhelst","year":"2012","unstructured":"Verhelst K, Carpentier I, Kreike M, Meloni L, Verstrepen L, Kensche T, Dikic I and Beyaert R. A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7. EMBO J 2012; 31: 3845-3855.","journal-title":"EMBO J"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/ncb3609","article-title":"A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1","volume":"19","author":"Lee","year":"2017","unstructured":"Lee JH, Jung SM, Yang KM, Bae E, Ahn SG, Park JS, Seo D, Kim M, Ha J, Lee J, Kim JH, Kim JH, Ooshima A, Park J, Shin D, Lee YS, Lee S, van Loo G, Jeong J, Kim SJ and Park SH. A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1. Nat Cell Biol 2017; 19: 1260-1273.","journal-title":"Nat Cell Biol"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s41419-020-03001-y","article-title":"A20 promotes melanoma progression via the activation of Akt pathway","volume":"11","author":"Ma","year":"2020","unstructured":"Ma J, Wang H, Guo S, Yi X, Zhao T, Liu Y, Shi Q, Gao T, Li C and Guo W. A20 promotes melanoma progression via the activation of Akt pathway. Cell Death Dis 2020; 11: 794.","journal-title":"Cell Death Dis"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","article-title":"TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas","volume":"114","author":"Honma","year":"2009","unstructured":"Honma K, Tsuzuki S, Nakagawa M, Tagawa H, Nakamura S, Morishima Y and Seto M. TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood 2009; 114: 2467-2475.","journal-title":"Blood"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nature07969","article-title":"Frequent inactivation of A20 in B-cell lymphomas","volume":"459","author":"Kato","year":"2009","unstructured":"Kato M, Sanada M, Kato I, Sato Y, Takita J, Takeuchi K, Niwa A, Chen Y, Nakazaki K, Nomoto J, Asakura Y, Muto S, Tamura A, Iio M, Akatsuka Y, Hayashi Y, Mori H, Igarashi T, Kurokawa M, Chiba S, Mori S, Ishikawa Y, Okamoto K, Tobinai K, Nakagama H, Nakahata T, Yoshino T, Kobayashi Y and Ogawa S. Frequent inactivation of A20 in B-cell lymphomas. Nature 2009; 459: 712-716.","journal-title":"Nature"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"21479","DOI":"10.1002\/jcp.28877","article-title":"Emerging role of zinc finger protein A20 as a suppressor of hepatocellular carcinoma","volume":"234","author":"PS","year":"2019","unstructured":"Yi PS, Shu Y, Bi WX, Zheng XB, Feng WJ, He LY and Li JS. Emerging role of zinc finger protein A20 as a suppressor of hepatocellular carcinoma. J Cell Physiol 2019; 234: 21479-21484.","journal-title":"J Cell Physiol"},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"Martens A and van Loo G. A20 at the crossroads of cell death, inflammation, and autoimmunity. Cold Spring Harb Perspect Biol 2020; 12: a036418.","DOI":"10.1101\/cshperspect.a036418"},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"Unda BK, Chalil L, Yoon S, Kilpatrick S, Irwin C, Xing S, Murtaza N, Cheng A, Brown C, Afonso A, McCready E, Ronen GM, Howe J, Caye-Eude A, Verloes A, Doble BW, Faivre L, Vitobello A, Scherer SW, Lu Y, Penzes P and Singh KK. Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome. Mol Psychiatry 2023; 28: 1747-1769.","DOI":"10.1038\/s41380-022-01937-5"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1101\/gad.332395.119","article-title":"Crosstalk between Lys63- and Lys11-polyubiquitin signaling at DNA damage sites is driven by Cezanne","volume":"33","author":"Wu","year":"2019","unstructured":"Wu X, Liu S, Sagum C, Chen J, Singh R, Chaturvedi A, Horton JR, Kashyap TR, Fushman D, Cheng X, Bedford MT and Wang B. Crosstalk between Lys63- and Lys11-polyubiquitin signaling at DNA damage sites is driven by Cezanne. Genes Dev 2019; 33: 1702-1717.","journal-title":"Genes Dev"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1080\/15548627.2020.1761652","article-title":"High-throughput screening of functional deubiquitinating enzymes in autophagy","volume":"17","author":"Tian","year":"2021","unstructured":"Tian S, Jin S, Wu Y, Liu T, Luo M, Ou J, Xie W and Cui J. High-throughput screening of functional deubiquitinating enzymes in autophagy. Autophagy 2021; 17: 1367-1378.","journal-title":"Autophagy"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature22344","article-title":"TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling","volume":"545","author":"Wang","year":"2017","unstructured":"Wang B, Jie Z, Joo D, Ordureau A, Liu P, Gan W, Guo J, Zhang J, North BJ, Dai X, Cheng X, Bian X, Zhang L, Harper JW, Sun SC and Wei W. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. Nature 2017; 545: 365-369.","journal-title":"Nature"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature11831","article-title":"OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3","volume":"494","author":"Hu","year":"2013","unstructured":"Hu H, Brittain GC, Chang JH, Puebla-Osorio N, Jin J, Zal A, Xiao Y, Cheng X, Chang M, Fu YX, Zal T, Zhu C and Sun SC. OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3. Nature 2013; 494: 371-374.","journal-title":"Nature"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.dld.2023.06.026","article-title":"OTUD7B deubiquitinates and stabilizes YAP1 to upregulate NUAK2 expression, thus accelerating gastric cancer procession","volume":"56","author":"Guo","year":"2024","unstructured":"Guo Z and Guo L. OTUD7B deubiquitinates and stabilizes YAP1 to upregulate NUAK2 expression, thus accelerating gastric cancer procession. Dig Liver Dis 2024; 56: 352-362.","journal-title":"Dig Liver Dis"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41419-022-05379-3","article-title":"RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling pathway","volume":"13","author":"Chen","year":"2022","unstructured":"Chen S, Cai K, Zheng D, Liu Y, Li L, He Z, Sun C and Yu C. RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling pathway. Cell Death Dis 2022; 13: 945.","journal-title":"Cell Death Dis"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41419-021-03785-7","article-title":"OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation","volume":"12","author":"Tang","year":"2021","unstructured":"Tang J, Wu Z, Tian Z, Chen W and Wu G. OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation. Cell Death Dis 2021; 12: 534.","journal-title":"Cell Death Dis"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13046-020-01751-3","article-title":"OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3","volume":"39","author":"Zhang","year":"2020","unstructured":"Zhang B, Yang C, Wang R, Wu J, Zhang Y, Liu D, Sun X, Li X, Ren H and Qin S. OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3. J Exp Clin Cancer Res 2020; 39: 244.","journal-title":"J Exp Clin Cancer Res"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.7150\/thno.103012","article-title":"OTUD7B is a new deubiquitinase targeting p53","volume":"15","author":"Ding","year":"2025","unstructured":"Ding C, Cao L, Wang R, Wu Q, Li M, Zhang J, Thorne RF, Li J, Ma J, Wu M and Cang S. OTUD7B is a new deubiquitinase targeting p53. Theranostics 2025; 15: 2121-2138.","journal-title":"Theranostics"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40364-025-00766-2","article-title":"Deubiquitinase OTUD7B stabilizes HNF4α to alleviate pressure overload-induced cardiac hypertrophy by regulating fatty acid oxidation and inhibiting ferroptosis","volume":"13","author":"Zheng","year":"2025","unstructured":"Zheng R, Song W, Wang C, Du X, Liu C, Sun X and Lu C. Deubiquitinase OTUD7B stabilizes HNF4α to alleviate pressure overload-induced cardiac hypertrophy by regulating fatty acid oxidation and inhibiting ferroptosis. Biomark Res 2025; 13: 53.","journal-title":"Biomark Res"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nsmb.2169","article-title":"An ankyrin-repeat ubiquitin-binding domain determines TRABID’s specificity for atypical ubiquitin chains","volume":"19","author":"Licchesi","year":"2011","unstructured":"Licchesi JD, Mieszczanek J, Mevissen TE, Rutherford TJ, Akutsu M, Virdee S, El Oualid F, Chin JW, Ovaa H, Bienz M and Komander D. An ankyrin-repeat ubiquitin-binding domain determines TRABID’s specificity for atypical ubiquitin chains. Nat Struct Mol Biol 2011; 19: 62-71.","journal-title":"Nat Struct Mol Biol"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41467-021-21715-1","article-title":"VPS34 K29\/K48 branched ubiquitination governed by UBE3C and TRABID regulates autophagy, proteostasis and liver metabolism","volume":"12","author":"Chen","year":"2021","unstructured":"Chen YH, Huang TY, Lin YT, Lin SY, Li WH, Hsiao HJ, Yan RL, Tang HW, Shen ZQ, Chen GC, Wu KP, Tsai TF and Chen RH. VPS34 K29\/K48 branched ubiquitination governed by UBE3C and TRABID regulates autophagy, proteostasis and liver metabolism. Nat Commun 2021; 12: 1322.","journal-title":"Nat Commun"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1101\/gad.463208","article-title":"Trabid, a new positive regulator of Wnt-induced transcription with preference for binding and cleaving K63-linked ubiquitin chains","volume":"22","author":"Tran","year":"2008","unstructured":"Tran H, Hamada F, Schwarz-Romond T and Bienz M. Trabid, a new positive regulator of Wnt-induced transcription with preference for binding and cleaving K63-linked ubiquitin chains. Genes Dev 2008; 22: 528-542.","journal-title":"Genes Dev"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.celrep.2018.03.078","article-title":"ZRANB1 is an EZH2 deubiquitinase and a potential therapeutic target in breast cancer","volume":"23","author":"Zhang","year":"2018","unstructured":"Zhang P, Xiao Z, Wang S, Zhang M, Wei Y, Hang Q, Kim J, Yao F, Rodriguez-Aguayo C, Ton BN, Lee M, Wang Y, Zhou Z, Zeng L, Hu X, Lawhon SE, Siverly AN, Su X, Li J, Xie X, Cheng X, Liu LC, Chang HW, Chiang SF, Lopez-Berestein G, Sood AK, Chen J, You MJ, Sun SC, Liang H, Huang Y, Yang X, Sun D, Sun Y, Hung MC and Ma L. ZRANB1 is an EZH2 deubiquitinase and a potential therapeutic target in breast cancer. Cell Rep 2018; 23: 823-837.","journal-title":"Cell Rep"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"110200","DOI":"10.1016\/j.cellsig.2021.110200","article-title":"ZRANB1 enhances stem-cell-like features and accelerates tumor progression by regulating Sox9-mediated USP22\/Wnt\/β-catenin pathway in colorectal cancer","volume":"90","author":"Miao","year":"2022","unstructured":"Miao D, Wang Y, Jia Y, Tong J, Jiang S and Liu L. ZRANB1 enhances stem-cell-like features and accelerates tumor progression by regulating Sox9-mediated USP22\/Wnt\/β-catenin pathway in colorectal cancer. Cell Signal 2022; 90: 110200.","journal-title":"Cell Signal"},{"key":"ref123","unstructured":"Li Q, Chao Q, Liu Y, Fang J, Xie J, Zhen J, Ding Y, Fu B, Ke Y, Xiao F, Wu H, Huang Z, Hao H and Huang D. Deubiquitinase ZRANB1 drives hepatocellular carcinoma progression through SP1-LOXL2 axis. Am J Cancer Res 2021; 11: 4807-4825."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41418-018-0119-2","article-title":"Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1","volume":"26","author":"Zhu","year":"2019","unstructured":"Zhu Y, Qu C, Hong X, Jia Y, Lin M, Luo Y, Lin F, Xie X, Xie X, Huang J, Wu Q, Qiu X, Piao D, Xing Y, Yu T, Lu Y, Huang Q, Yu C, Jin J and Zhang Z. Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1. Cell Death Differ 2019; 26: 306-320.","journal-title":"Cell Death Differ"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1038\/s41467-023-38784-z","article-title":"TRABID inhibition activates cGAS\/STING-mediated anti-tumor immunity through mitosis and autophagy dysregulation","volume":"14","author":"Chen","year":"2023","unstructured":"Chen YH, Chen HH, Wang WJ, Chen HY, Huang WS, Kao CH, Lee SR, Yeat NY, Yan RL, Chan SJ, Wu KP and Chen RH. TRABID inhibition activates cGAS\/STING-mediated anti-tumor immunity through mitosis and autophagy dysregulation. Nat Commun 2023; 14: 3050.","journal-title":"Nat Commun"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1083\/jcb.200208112","article-title":"VCIP135, a novel essential factor for p97\/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo","volume":"159","author":"Uchiyama","year":"2002","unstructured":"Uchiyama K, Jokitalo E, Kano F, Murata M, Zhang X, Canas B, Newman R, Rabouille C, Pappin D, Freemont P and Kondo H. VCIP135, a novel essential factor for p97\/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo. J Cell Biol 2002; 159: 855-866.","journal-title":"J Cell Biol"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"105540","DOI":"10.1016\/j.jbc.2023.105540","article-title":"VCIP135 associates with both the N- and C-terminal regions of p97 ATPase","volume":"300","author":"Nakayama","year":"2024","unstructured":"Nakayama S and Kondo H. VCIP135 associates with both the N- and C-terminal regions of p97 ATPase. J Biol Chem 2024; 300: 105540.","journal-title":"J Biol Chem"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"113622","DOI":"10.1016\/j.intimp.2024.113622","article-title":"VCPIP1 negatively regulates NF-κB signaling pathways by deubiquitinating and stabilizing Erbin in MDP-stimulated macrophages","volume":"143","author":"Zuo","year":"2024","unstructured":"Zuo J, Wu D, Zhang Y, Luo H, Jing G, Yuan M, Fang Q, Yang C, Wang X, Wu X and Song X. VCPIP1 negatively regulates NF-κB signaling pathways by deubiquitinating and stabilizing Erbin in MDP-stimulated macrophages. Int Immunopharmacol 2024; 143: 113622.","journal-title":"Int Immunopharmacol"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cell.2013.05.014","article-title":"OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin","volume":"153","author":"Keusekotten","year":"2013","unstructured":"Keusekotten K, Elliott PR, Glockner L, Fiil BK, Damgaard RB, Kulathu Y, Wauer T, Hospenthal MK, Gyrd-Hansen M, Krappmann D, Hofmann K and Komander D. OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell 2013; 153: 1312-1326.","journal-title":"Cell"},{"key":"ref130","doi-asserted-by":"publisher","unstructured":"Damgaard RB, Elliott PR, Swatek KN, Maher ER, Stepensky P, Elpeleg O, Komander D and Berkun Y. OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death. EMBO Mol Med 2019; 11: e9324.","DOI":"10.15252\/emmm.201809324"},{"key":"ref131","doi-asserted-by":"publisher","unstructured":"Damgaard RB, Walker JA, Marco-Casanova P, Morgan NV, Titheradge HL, Elliott PR, McHale D, Maher ER, McKenzie ANJ and Komander D. The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity. Cell 2016; 166: 1215-1230, e20.","DOI":"10.1016\/j.cell.2016.07.019"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1080\/15548627.2020.1781393","article-title":"LUBAC and OTULIN regulate autophagy initiation and maturation by mediating the linear ubiquitination and the stabilization of ATG13","volume":"17","author":"Chu","year":"2021","unstructured":"Chu Y, Kang Y, Yan C, Yang C, Zhang T, Huo H and Liu Y. LUBAC and OTULIN regulate autophagy initiation and maturation by mediating the linear ubiquitination and the stabilization of ATG13. Autophagy 2021; 17: 1684-1699.","journal-title":"Autophagy"},{"key":"ref133","doi-asserted-by":"publisher","unstructured":"Fu Y, Wang H, Dai H, Zhu Q, Cui CP, Sun X, Li Y, Deng Z, Zhou X, Ge Y, Peng Z, Yuan C, Wu B, Yang X, Li R, Liu CH, He F, Wei W and Zhang L. OTULIN allies with LUBAC to govern angiogenesis by editing ALK1 linear polyubiquitin. Mol Cell 2021; 81: 3187-3204, e7.","DOI":"10.1016\/j.molcel.2021.05.031"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-018-0256-2","article-title":"OTULIN limits cell death and inflammation by deubiquitinating LUBAC","volume":"559","author":"Heger","year":"2018","unstructured":"Heger K, Wickliffe KE, Ndoja A, Zhang J, Murthy A, Dugger DL, Maltzman A, de Sousa E Melo F, Hung J, Zeng Y, Verschueren E, Kirkpatrick DS, Vucic D, Lee WP, Roose-Girma M, Newman RJ, Warming S, Hsiao YC, Kőműves LG, Webster JD, Newton K and Dixit VM. OTULIN limits cell death and inflammation by deubiquitinating LUBAC. Nature 2018; 559: 120-124.","journal-title":"Nature"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","unstructured":"Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, Meyerson M, Gabriel SB, Lander ES and Getz G. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014; 505: 495-501.","journal-title":"Nature"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nrd1902","article-title":"Exploiting the PI3K\/AKT pathway for cancer drug discovery","volume":"4","author":"Hennessy","year":"2005","unstructured":"Hennessy BT, Smith DL, Ram PT, Lu Y and Mills GB. Exploiting the PI3K\/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005; 4: 988-1004.","journal-title":"Nat Rev Drug Discov"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.2217\/pgs.15.122","article-title":"PTEN and PI3K\/AKT in non-small-cell lung cancer","volume":"16","author":"P&#xE9","year":"2015","unstructured":"Pérez-Ramírez C, Cañadas-Garre M, Molina MÁ, Faus-Dáder MJ and Calleja-Hernández MÁ. PTEN and PI3K\/AKT in non-small-cell lung cancer. Pharmacogenomics 2015; 16: 1843-1862.","journal-title":"Pharmacogenomics"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1038\/s41598-023-31759-6","article-title":"Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome","volume":"13","author":"Vidotto","year":"2023","unstructured":"Vidotto T, Melo CM, Lautert-Dutra W, Chaves LP, Reis RB and Squire JA. Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome. Sci Rep 2023; 13: 5049.","journal-title":"Sci Rep"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/ijms20030755","article-title":"mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy","volume":"20","author":"Tian","year":"2019","unstructured":"Tian T, Li X and Zhang J. mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy. Int J Mol Sci 2019; 20: 75.","journal-title":"Int J Mol Sci"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","unstructured":"Saxton RA and Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell 2017; 168: 960-976.","journal-title":"Cell"},{"key":"ref141","doi-asserted-by":"publisher","unstructured":"Liberti MV and Locasale JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 2016; 41: 211-218.","DOI":"10.1016\/j.tibs.2015.12.001"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41420-022-00839-3","article-title":"OTUB2 regulates KRT80 stability via deubiquitination and promotes tumour proliferation in gastric cancer","volume":"8","author":"Ouyang","year":"2022","unstructured":"Ouyang S, Zeng Z, Liu Z, Zhang Z, Sun J, Wang X, Ma M, Ye X, Yu J and Kang W. OTUB2 regulates KRT80 stability via deubiquitination and promotes tumour proliferation in gastric cancer. Cell Death Discov 2022; 8: 45.","journal-title":"Cell Death Discov"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/tox.23852","article-title":"RBM15 m(6) A modification-mediated OTUB2 upregulation promotes cervical cancer progression via the AKT\/mTOR signaling","volume":"38","author":"Song","year":"2023","unstructured":"Song Y and Wu Q. RBM15 m(6) A modification-mediated OTUB2 upregulation promotes cervical cancer progression via the AKT\/mTOR signaling. Environ Toxicol 2023; 38: 2155-2164.","journal-title":"Environ Toxicol"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.7150\/ijbs.68980","article-title":"OTUD1 stabilizes PTEN to inhibit the PI3K\/AKT and TNF-alpha\/NF-kappaB signaling pathways and sensitize ccRCC to TKIs","volume":"18","author":"Liu","year":"2022","unstructured":"Liu W, Yan B, Yu H, Ren J, Peng M, Zhu L, Wang Y, Jin X and Yi L. OTUD1 stabilizes PTEN to inhibit the PI3K\/AKT and TNF-alpha\/NF-kappaB signaling pathways and sensitize ccRCC to TKIs. Int J Biol Sci 2022; 18: 1401-1414.","journal-title":"Int J Biol Sci"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/ncb3218","article-title":"Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis","volume":"17","author":"Yuan","year":"2015","unstructured":"Yuan L, Lv Y, Li H, Gao H, Song S, Zhang Y, Xing G, Kong X, Wang L, Li Y, Zhou T, Gao D, Xiao ZX, Yin Y, Wei W, He F and Zhang L. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis. Nat Cell Biol 2015; 17: 1169-1181.","journal-title":"Nat Cell Biol"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.2147\/DDDT.S135993","article-title":"Downregulation of A20 increases the cytotoxicity of IFN-γ in hepatocellular carcinoma cells","volume":"11","author":"Yin","year":"2017","unstructured":"Yin L, Fang Z, Shen NJ, Qiu YH, Li AJ and Zhang YJ. Downregulation of A20 increases the cytotoxicity of IFN-γ in hepatocellular carcinoma cells. Drug Des Devel Ther 2017; 11: 2841-2850.","journal-title":"Drug Des Devel Ther"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fonc.2019.00862","article-title":"Upregulation of OTUD7B (Cezanne) promotes tumor progression via AKT\/VEGF pathway in lung squamous carcinoma and adenocarcinoma","volume":"9","author":"Lin","year":"2019","unstructured":"Lin DD, Shen Y, Qiao S, Liu WW, Zheng L, Wang YN, Cui N, Wang YF, Zhao S and Shi JH. Upregulation of OTUD7B (Cezanne) promotes tumor progression via AKT\/VEGF pathway in lung squamous carcinoma and adenocarcinoma. Front Oncol 2019; 9: 862.","journal-title":"Front Oncol"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s12672-024-01073-2","article-title":"OTUD7B knockdown inhibits proliferation and autophagy through AKT\/mTOR signaling pathway in human prostate cancer cell","volume":"15","author":"Kim","year":"2024","unstructured":"Kim YJ, Lee HJ, Kim KH, Cho SP and Jung JY. OTUD7B knockdown inhibits proliferation and autophagy through AKT\/mTOR signaling pathway in human prostate cancer cell. Discov Oncol 2024; 15: 247.","journal-title":"Discov Oncol"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41418-020-0532-1","article-title":"OTULIN protects the liver against cell death, inflammation, fibrosis, and cancer","volume":"27","author":"Damgaard","year":"2020","unstructured":"Damgaard RB, Jolin HE, Allison MED, Davies SE, Titheradge HL, McKenzie ANJ and Komander D. OTULIN protects the liver against cell death, inflammation, fibrosis, and cancer. Cell Death Differ 2020; 27: 1457-1474.","journal-title":"Cell Death Differ"},{"key":"ref150","doi-asserted-by":"publisher","unstructured":"Verboom L, Martens A, Priem D, Hoste E, Sze M, Vikkula H, Van Hove L, Voet S, Roels J, Maelfait J, Bongiovanni L, de Bruin A, Scott CL, Saeys Y, Pasparakis M, Bertrand MJM and van Loo G. OTULIN prevents liver inflammation and hepatocellular carcinoma by inhibiting FADD- and RIPK1 kinase-mediated hepatocyte apoptosis. Cell Rep 2020; 30: 2237-2247, e6.","DOI":"10.1016\/j.celrep.2020.01.028"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000512218","article-title":"Epithelial-Mesenchymal Transition (EMT) as a therapeutic target","volume":"211","author":"Jonckheere","year":"2022","unstructured":"Jonckheere S, Adams J, De Groote D, Campbell K, Berx G and Goossens S. Epithelial-Mesenchymal Transition (EMT) as a therapeutic target. Cells Tissues Organs 2022; 211: 157-182.","journal-title":"Cells Tissues Organs"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3390\/cells8050460","article-title":"The vicious cross-talk between tumor cells with an EMT phenotype and cells of the immune system","volume":"8","author":"Romeo","year":"2019","unstructured":"Romeo E, Caserta CA, Rumio C and Marcucci F. The vicious cross-talk between tumor cells with an EMT phenotype and cells of the immune system. Cells 2019; 8: 460.","journal-title":"Cells"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.trecan.2020.02.001","article-title":"Tumor plasticity and resistance to immunotherapy","volume":"6","author":"LA","year":"2020","unstructured":"Horn LA, Fousek K and Palena C. Tumor plasticity and resistance to immunotherapy. Trends Cancer 2020; 6: 432-441.","journal-title":"Trends Cancer"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.3390\/ijms25168972","article-title":"Factors determining epithelial-mesenchymal transition in cancer progression","volume":"25","author":"Tomecka","year":"2024","unstructured":"Tomecka P, Kunachowicz D, Górczyńska J, Gebuza M, Kuźnicki J, Skinderowicz K and Choromańska A. Factors determining epithelial-mesenchymal transition in cancer progression. Int J Mol Sci 2024; 25: 8972.","journal-title":"Int J Mol Sci"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/1476-4598-13-258","article-title":"OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer","volume":"13","author":"Zhou","year":"2014","unstructured":"Zhou Y, Wu J, Fu X, Du W, Zhou L, Meng X, Yu H, Lin J, Ye W, Liu J, Peng H, Liu RY, Pan C and Huang W. OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer. Mol Cancer 2014; 13: 258.","journal-title":"Mol Cancer"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"9106","DOI":"10.1080\/21655979.2022.2057897","article-title":"Overexpression of OTU domain-containing ubiquitin aldehyde-binding protein 1 exacerbates colorectal cancer malignancy by inhibiting protein degradation of β-Catenin via Ubiquitin-proteasome pathway","volume":"13","author":"Ye","year":"2022","unstructured":"Ye D, Wang S, Wang X, Lin Y, Huang Y and Chi P. Overexpression of OTU domain-containing ubiquitin aldehyde-binding protein 1 exacerbates colorectal cancer malignancy by inhibiting protein degradation of β-Catenin via Ubiquitin-proteasome pathway. Bioengineered 2022; 13: 9106-9116.","journal-title":"Bioengineered"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1038\/s41388-018-0224-1","article-title":"OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability","volume":"37","author":"Zhou","year":"2018","unstructured":"Zhou H, Liu Y, Zhu R, Ding F, Cao X, Lin D and Liu Z. OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability. Oncogene 2018; 37: 3356-3368.","journal-title":"Oncogene"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41388-018-0472-0","article-title":"The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3\/A20","volume":"38","author":"Lee","year":"2019","unstructured":"Lee E, Ouzounova M, Piranlioglu R, Ma MT, Guzel M, Marasco D, Chadli A, Gestwicki JE, Cowell JK, Wicha MS, Hassan KA and Korkaya H. The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3\/A20. Oncogene 2019; 38: 469-482.","journal-title":"Oncogene"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbrc.2022.07.109","article-title":"TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells","volume":"625","author":"Chen","year":"2022","unstructured":"Chen Y and Zhang X. TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. Biochem Biophys Res Commun 2022; 625: 23-30.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref160","doi-asserted-by":"publisher","unstructured":"Salik B, Yi H, Hassan N, Santiappillai N, Vick B, Connerty P, Duly A, Trahair T, Woo AJ, Beck D, Liu T, Spiekermann K, Jeremias I, Wang J, Kavallaris M, Haber M, Norris MD, Liebermann DA, D’Andrea RJ, Murriel C and Wang JY. Targeting RSPO3-LGR4 signaling for leukemia stem cell eradication in acute myeloid leukemia. Cancer Cell 2020; 38: 263-278, e6.","DOI":"10.1016\/j.ccell.2020.05.014"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/β-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","unstructured":"Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y, Dong Q and Wei X. Wnt\/β-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol 2024; 17: 46.","journal-title":"J Hematol Oncol"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/1476-4598-9-236","article-title":"Convergence between Wnt-β-catenin and EGFR signaling in cancer","volume":"9","author":"Hu","year":"2010","unstructured":"Hu T and Li C. Convergence between Wnt-β-catenin and EGFR signaling in cancer. Mol Cancer 2010; 9: 236.","journal-title":"Mol Cancer"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s13238-012-2913-9","article-title":"Hippo pathway in intestinal homeostasis and tumorigenesis","volume":"3","author":"Chen","year":"2012","unstructured":"Chen L, Qin F, Deng X, Avruch J and Zhou D. Hippo pathway in intestinal homeostasis and tumorigenesis. Protein Cell 2012; 3: 305-310.","journal-title":"Protein Cell"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10565-019-09502-7","article-title":"Temozolomide induces activation of Wnt\/β-catenin signaling in glioma cells via PI3K\/Akt pathway: implications in glioma therapy","volume":"36","author":"VS","year":"2020","unstructured":"Tomar VS, Patil V and Somasundaram K. Temozolomide induces activation of Wnt\/β-catenin signaling in glioma cells via PI3K\/Akt pathway: implications in glioma therapy. Cell Biol Toxicol 2020; 36: 273-278.","journal-title":"Cell Biol Toxicol"},{"key":"ref165","unstructured":"Xu X, Wu G, Han K, Cui X, Feng Y, Mei X, Yang P, You W and Yang Y. Inhibition of OTUB2 suppresses colorectal cancer cell growth by regulating β-Catenin signaling. Am J Cancer Res 2023; 13: 5382-5393."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41420-021-00556-3","article-title":"M2 macrophage-derived extracellular vesicles facilitate CD8+T cell exhaustion in hepatocellular carcinoma via the miR-21-5p\/YOD1\/YAP\/β-catenin pathway","volume":"7","author":"Pu","year":"2021","unstructured":"Pu J, Xu Z, Nian J, Fang Q, Yang M, Huang Y, Li W, Ge B, Wang J and Wei H. M2 macrophage-derived extracellular vesicles facilitate CD8+T cell exhaustion in hepatocellular carcinoma via the miR-21-5p\/YOD1\/YAP\/β-catenin pathway. Cell Death Discov 2021; 7: 182.","journal-title":"Cell Death Discov"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41419-023-06035-0","article-title":"Deubiquitinase YOD1 suppresses tumor progression by stabilizing E3 ligase TRIM33 in head and neck squamous cell carcinoma","volume":"14","author":"Wu","year":"2023","unstructured":"Wu Y, Duan Y, Han W, Cao J, Ye B, Chen P, Li H, Wang Y, Liu J, Fang Y, Yue K, Wu Y, Wang X and Jing C. Deubiquitinase YOD1 suppresses tumor progression by stabilizing E3 ligase TRIM33 in head and neck squamous cell carcinoma. Cell Death Dis 2023; 14: 517.","journal-title":"Cell Death Dis"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"155689","DOI":"10.1016\/j.prp.2024.155689","article-title":"OTUD7B promotes cell migration and invasion, predicting poor prognosis of gastric cancer","volume":"264","author":"Liu","year":"2024","unstructured":"Liu XL, Zhao SY, Zhang MH, Zhang PZ and Liu XP. OTUD7B promotes cell migration and invasion, predicting poor prognosis of gastric cancer. Pathol Res Pract 2024; 264: 155689.","journal-title":"Pathol Res Pract"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1038\/s41467-020-17770-9","article-title":"ABL1-dependent OTULIN phosphorylation promotes genotoxic Wnt\/β-catenin activation to enhance drug resistance in breast cancers","volume":"11","author":"Wang","year":"2020","unstructured":"Wang W, Li M, Ponnusamy S, Chi Y, Xue J, Fahmy B, Fan M, Miranda-Carboni GA, Narayanan R, Wu J and Wu ZH. ABL1-dependent OTULIN phosphorylation promotes genotoxic Wnt\/β-catenin activation to enhance drug resistance in breast cancers. Nat Commun 2020; 11: 3965.","journal-title":"Nat Commun"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","article-title":"Mechanisms of Hippo pathway regulation","volume":"30","author":"Meng","year":"2016","unstructured":"Meng Z, Moroishi T and Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev 2016; 30: 1-17.","journal-title":"Genes Dev"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","article-title":"Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling","volume":"150","author":"FX","year":"2012","unstructured":"Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao J, Yuan H, Tumaneng K, Li H, Fu XD, Mills GB and Guan KL. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 2012; 150: 780-791.","journal-title":"Cell"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"661718","DOI":"10.3389\/fcell.2021.661718","article-title":"Mutations and copy number abnormalities of hippo pathway components in human cancers","volume":"9","author":"He","year":"2021","unstructured":"He Z, Li R and Jiang H. Mutations and copy number abnormalities of hippo pathway components in human cancers. Front Cell Dev Biol 2021; 9: 661718.","journal-title":"Front Cell Dev Biol"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1101\/gad.262816.115","article-title":"A YAP\/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis","volume":"29","author":"Moroishi","year":"2015","unstructured":"Moroishi T, Park HW, Qin B, Chen Q, Meng Z, Plouffe SW, Taniguchi K, Yu FX, Karin M, Pan D and Guan KL. A YAP\/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev 2015; 29: 1271-1284.","journal-title":"Genes Dev"},{"key":"ref174","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12575-022-00169-9","article-title":"OTUB2 Regulates YAP1\/TAZ to promotes the progression of esophageal squamous cell carcinoma","volume":"24","author":"Liu","year":"2022","unstructured":"Liu L, Cheng H, Ji M, Su L, Lu Z, Hu X, Guan Y, Xiao J, Ma L, Zhang W and Pu H. OTUB2 Regulates YAP1\/TAZ to promotes the progression of esophageal squamous cell carcinoma. Biol Proced Online 2022; 24: 10.","journal-title":"Biol Proced Online"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1073\/pnas.1620306114","article-title":"Deubiquitinase YOD1 potentiates YAP\/TAZ activities through enhancing ITCH stability","volume":"114","author":"Kim","year":"2017","unstructured":"Kim Y, Kim W, Song Y, Kim JR, Cho K, Moon H, Ro SW, Seo E, Ryu YM, Myung SJ and Jho EH. Deubiquitinase YOD1 potentiates YAP\/TAZ activities through enhancing ITCH stability. Proc Natl Acad Sci U S A 2017; 114: 4691-4696.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.canlet.2021.02.003","article-title":"OTUD5-mediated deubiquitination of YAP in macrophage promotes M2 phenotype polarization and favors triple-negative breast cancer progression","volume":"504","author":"Zhang","year":"2021","unstructured":"Zhang Y, Fan Y, Jing X, Zhao L, Liu T, Wang L, Zhang L, Gu S, Zhao X and Teng Y. OTUD5-mediated deubiquitination of YAP in macrophage promotes M2 phenotype polarization and favors triple-negative breast cancer progression. Cancer Lett 2021; 504: 104-115.","journal-title":"Cancer Lett"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"177002","DOI":"10.1016\/j.ejphar.2024.177002","article-title":"Dapagliflozin suppressed gastric cancer growth via regulating OTUD5 mediated YAP1 deubiquitination","volume":"983","author":"Ren","year":"2024","unstructured":"Ren K, Wang X, Ma R, Chen H, Min T, Ma Y, Xie X, Wang W, Deng X, Zhou Z, Li K, Zhu K, Hao N, Dang C, Sun T and Zhang H. Dapagliflozin suppressed gastric cancer growth via regulating OTUD5 mediated YAP1 deubiquitination. Eur J Pharmacol 2024; 983: 177002.","journal-title":"Eur J Pharmacol"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","unstructured":"Hayden MS and Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008; 132: 344-362.","journal-title":"Cell"},{"key":"ref179","doi-asserted-by":"publisher","unstructured":"Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009; 1: a001651.","DOI":"10.1101\/cshperspect.a001651"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","unstructured":"Kawai T and Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11: 373-384.","journal-title":"Nat Immunol"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41419-020-2399-y","article-title":"Life, death, and autophagy in cancer: NF-κB turns up everywhere","volume":"11","author":"Verzella","year":"2020","unstructured":"Verzella D, Pescatore A, Capece D, Vecchiotti D, Ursini MV, Franzoso G, Alesse E and Zazzeroni F. Life, death, and autophagy in cancer: NF-κB turns up everywhere. Cell Death Dis 2020; 11: 210.","journal-title":"Cell Death Dis"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-κB signaling in inflammation","volume":"2","author":"Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D and Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther 2017; 2: 17023.","journal-title":"Signal Transduct Target Ther"},{"key":"ref183","doi-asserted-by":"publisher","unstructured":"Israël A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol 2010; 2: a000158.","DOI":"10.1101\/cshperspect.a000158"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","article-title":"Regulation and function of NF-kappaB transcription factors in the immune system","volume":"27","author":"Vallabhapurapu","year":"2009","unstructured":"Vallabhapurapu S and Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009; 27: 693-733.","journal-title":"Annu Rev Immunol"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41417-024-00811-6","article-title":"NF-κB role on tumor proliferation, migration, invasion and immune escape","volume":"31","author":"Khan","year":"2024","unstructured":"Khan A, Zhang Y, Ma N, Shi J and Hou Y. NF-κB role on tumor proliferation, migration, invasion and immune escape. Cancer Gene Ther 2024; 31: 1599-1610.","journal-title":"Cancer Gene Ther"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-κB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","unstructured":"Hoesel B and Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer 2013; 12: 86.","journal-title":"Mol Cancer"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.1038\/s41467-023-42332-0","article-title":"The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer","volume":"14","author":"JJ","year":"2023","unstructured":"Li JJ, Wang JH, Tian T, Liu J, Zheng YQ, Mo HY, Sheng H, Chen YX, Wu QN, Han Y, Liao K, Pan YQ, Zeng ZL, Liu ZX, Yang W, Xu RH and Ju HQ. The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer. Nat Commun 2023; 14: 6690.","journal-title":"Nat Commun"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00018-022-04139-y","article-title":"A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection","volume":"79","author":"Lim","year":"2022","unstructured":"Lim MCC, Maubach G, Birkl-Toeglhofer AM, Haybaeck J, Vieth M and Naumann M. A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection. Cell Mol Life Sci 2022; 79: 102.","journal-title":"Cell Mol Life Sci"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/nrclinonc.2013.197","article-title":"Diffuse large B-cell lymphoma-treatment approaches in the molecular era","volume":"11","author":"Roschewski","year":"2014","unstructured":"Roschewski M, Staudt LM and Wilson WH. Diffuse large B-cell lymphoma-treatment approaches in the molecular era. Nat Rev Clin Oncol 2014; 11: 12-23.","journal-title":"Nat Rev Clin Oncol"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1038\/s41401-025-01527-5","article-title":"Nicotine promotes the progression and metastasis of non-small cell lung cancer by modulating the OTUB1-c-Myc-EZH2 axis","volume":"46","author":"Huang","year":"2025","unstructured":"Huang H, Ding C, Zhao WH, Zhang HB, Zhao ZX, Li XG, Wang YJ, Chen PJ, Li BS, Li XB, Li YW, Liu HY and Chen J. Nicotine promotes the progression and metastasis of non-small cell lung cancer by modulating the OTUB1-c-Myc-EZH2 axis. Acta Pharmacol Sin 2025; 46: 2509-2521.","journal-title":"Acta Pharmacol Sin"},{"key":"ref191","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41401-024-01366-w","article-title":"Inhibiting the Otub1\/phosphorylated STAT3 axis for the treatment of non-small cell lung cancer","volume":"46","author":"Liu","year":"2025","unstructured":"Liu ZY, Zhang YW, Zhuang HX, Ou YJ, Jiang QY, Li PF, He YM, Ren Y and Mao XL. Inhibiting the Otub1\/phosphorylated STAT3 axis for the treatment of non-small cell lung cancer. Acta Pharmacol Sin 2025; 46: 184-195.","journal-title":"Acta Pharmacol Sin"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1038\/s41418-022-00971-8","article-title":"Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis","volume":"29","author":"Han","year":"2022","unstructured":"Han X, Ren C, Lu C, Qiao P, Yang T and Yu Z. Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis. Cell Death Differ 2022; 29: 1864-1873.","journal-title":"Cell Death Differ"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/onc.2015.208","article-title":"OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance","volume":"35","author":"Karunarathna","year":"2016","unstructured":"Karunarathna U, Kongsema M, Zona S, Gong C, Cabrera E, Gomes AR, Man EP, Khongkow P, Tsang JW, Khoo US, Medema RH, Freire R and Lam EW. OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance. Oncogene 2016; 35: 1433-1444.","journal-title":"Oncogene"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13578-020-00408-0","article-title":"OTUB1-mediated deubiquitination of FOXM1 up-regulates ECT-2 to promote tumor progression in renal cell carcinoma","volume":"10","author":"Zhou","year":"2020","unstructured":"Zhou K, Mai H, Zheng S, Cai W, Yang X, Chen Z and Zhan B. OTUB1-mediated deubiquitination of FOXM1 up-regulates ECT-2 to promote tumor progression in renal cell carcinoma. Cell Biosci 2020; 10: 50.","journal-title":"Cell Biosci"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jare.2025.01.035","article-title":"Ailanthone induces triple-negative breast cancer cells death involving the inhibition of OTUB1-mediated ERRα deubiquitylation","volume":"77","author":"Zhang","year":"2025","unstructured":"Zhang Z, Huang W, Wang L, Li G, Xu F, Wu P, Luo C, Huang Q, Kuang W, Liu Z, Jiang Y, Zhao X, Zhang Y, Ye W, Li J, Ma N and Wang J. Ailanthone induces triple-negative breast cancer cells death involving the inhibition of OTUB1-mediated ERRα deubiquitylation. J Adv Res 2025; 77: 779-791.","journal-title":"J Adv Res"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/abbs\/gmx056","article-title":"Expression of OTUB1 in hepatocellular carcinoma and its effects on HCC cell migration and invasion","volume":"49","author":"Ni","year":"2017","unstructured":"Ni Q, Chen J, Li X, Xu X, Zhang N, Zhou A, Zhou B, Lu Q and Chen Z. Expression of OTUB1 in hepatocellular carcinoma and its effects on HCC cell migration and invasion. Acta Biochim Biophys Sin (Shanghai) 2017; 49: 680-688.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref197","unstructured":"Yuan L, Yuan P, Yuan H, Wang Z, Run Z, Chen G, Zhao P and Xu B. miR-542-3p inhibits colorectal cancer cell proliferation, migration and invasion by targeting OTUB1. Am J Cancer Res 2017; 7: 159-172."},{"key":"ref198","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41419-024-07057-y","article-title":"CircSEC24B activates autophagy and induces chemoresistance of colorectal cancer via OTUB1-mediated deubiquitination of SRPX2","volume":"15","author":"Wang","year":"2024","unstructured":"Wang D, Li Y, Chang W, Feng M, Yang Y, Zhu X, Liu Z and Fu Y. CircSEC24B activates autophagy and induces chemoresistance of colorectal cancer via OTUB1-mediated deubiquitination of SRPX2. Cell Death Dis 2024; 15: 693.","journal-title":"Cell Death Dis"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12943-014-0280-2","article-title":"OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo","volume":"14","author":"Iglesias-Gato D","year":"2015","unstructured":"Iglesias-Gato D, Chuan YC, Jiang N, Svensson C, Bao J, Paul I, Egevad L, Kessler BM, Wikström P, Niu Y and Flores-Morales A. OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo. Mol Cancer 2015; 14: 8.","journal-title":"Mol Cancer"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"10980","DOI":"10.1111\/jcmm.17020","article-title":"The deubiquitinase OTUB1 fosters papillary thyroid carcinoma growth through EYA1 stabilization","volume":"25","author":"Xie","year":"2021","unstructured":"Xie P, Chao Q, Mao J, Liu Y, Fang J, Xie J, Zhen J, Ding Y, Fu B, Ke Y and Huang D. The deubiquitinase OTUB1 fosters papillary thyroid carcinoma growth through EYA1 stabilization. J Cell Mol Med 2021; 25: 10980-10989.","journal-title":"J Cell Mol Med"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12195-022-00720-4","article-title":"OTUB2 promotes proliferation and migration of hepatocellular carcinoma cells by PJA1 deubiquitylation","volume":"15","author":"Hu","year":"2022","unstructured":"Hu G, Yang J, Zhang H, Huang Z and Yang H. OTUB2 promotes proliferation and migration of hepatocellular carcinoma cells by PJA1 deubiquitylation. Cell Mol Bioeng 2022; 15: 281-292.","journal-title":"Cell Mol Bioeng"},{"key":"ref202","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1128\/JVI.73.6.5181-5185.1999","article-title":"Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak","volume":"73","author":"Marshall","year":"1999","unstructured":"Marshall WL, Yim C, Gustafson E, Graf T, Sage DR, Hanify K, Williams L, Fingeroth J and Finberg RW. Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. J Virol 1999; 73: 5181-5185.","journal-title":"J Virol"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"167132","DOI":"10.1016\/j.bbadis.2024.167132","article-title":"OTUD1 enhances gastric cancer aggressiveness by deubiquitinating EBV-encoded protein BALF1 to stabilize the apoptosis inhibitor Bcl-2","volume":"1870","author":"Lin","year":"2024","unstructured":"Lin H, Han Y, Sang Y, Wu Y, Tian M, Chen X, Lin X and Lin X. OTUD1 enhances gastric cancer aggressiveness by deubiquitinating EBV-encoded protein BALF1 to stabilize the apoptosis inhibitor Bcl-2. Biochim Biophys Acta Mol Basis Dis 2024; 1870: 167132.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref204","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/j.apsb.2021.10.020","article-title":"Blockade of deubiquitinase YOD1 degrades oncogenic PML\/RARα and eradicates acute promyelocytic leukemia cells","volume":"12","author":"Shao","year":"2022","unstructured":"Shao X, Chen Y, Wang W, Du W, Zhang X, Cai M, Bing S, Cao J, Xu X, Yang B, He Q and Ying M. Blockade of deubiquitinase YOD1 degrades oncogenic PML\/RARα and eradicates acute promyelocytic leukemia cells. Acta Pharm Sin B 2022; 12: 1856-1870.","journal-title":"Acta Pharm Sin B"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1038\/s41467-019-10824-7","article-title":"The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis","volume":"10","author":"Du","year":"2019","unstructured":"Du T, Li H, Fan Y, Yuan L, Guo X, Zhu Q, Yao Y, Li X, Liu C, Yu X, Liu Z, Cui CP, Han C and Zhang L. The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis. Nat Commun 2019; 10: 2914.","journal-title":"Nat Commun"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1038\/s41418-020-0571-7","article-title":"Ubiquitin ligase CHIP regulates OTUD3 stability and suppresses tumour metastasis in lung cancer","volume":"27","author":"Zhang","year":"2020","unstructured":"Zhang P, Li C, Li H, Yuan L, Dai H, Peng Z, Deng Z, Chang Z, Cui CP and Zhang L. Ubiquitin ligase CHIP regulates OTUD3 stability and suppresses tumour metastasis in lung cancer. Cell Death Differ 2020; 27: 3177-3195.","journal-title":"Cell Death Differ"},{"key":"ref207","doi-asserted-by":"publisher","first-page":"19317","DOI":"10.18632\/aging.203293","article-title":"The deubiquitinase OTUD3 stabilizes ACTN4 to drive growth and metastasis of hepatocellular carcinoma","volume":"13","author":"Xie","year":"2021","unstructured":"Xie P, Chen Y, Zhang H, Zhou G, Chao Q, Wang J, Liu Y, Fang J, Xie J, Zhen J, Wang Z, Hao L and Huang D. The deubiquitinase OTUD3 stabilizes ACTN4 to drive growth and metastasis of hepatocellular carcinoma. Aging (Albany NY) 2021; 13: 19317-19338.","journal-title":"Aging (Albany NY)"},{"key":"ref208","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41467-018-08225-3","article-title":"The p300\/YY1\/miR-500a-5p\/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer","volume":"10","author":"Tang","year":"2019","unstructured":"Tang W, Zhou W, Xiang L, Wu X, Zhang P, Wang J, Liu G, Zhang W, Peng Y, Huang X, Cai J, Bai Y, Bai L, Zhu W, Gu H, Xiong J, Ye C, Li A, Liu S and Wang J. The p300\/YY1\/miR-500a-5p\/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer. Nat Commun 2019; 10: 663.","journal-title":"Nat Commun"},{"key":"ref209","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41419-024-06526-8","article-title":"Phosphorylation-dependent deubiquitinase OTUD3 regulates YY1 stability and promotes colorectal cancer progression","volume":"15","author":"Wu","year":"2024","unstructured":"Wu L, Zhou Z, Yu Y, Cheng C, Zhou S, Yan Y, Yu B, Zhang Y and Liu Z. Phosphorylation-dependent deubiquitinase OTUD3 regulates YY1 stability and promotes colorectal cancer progression. Cell Death Dis 2024; 15: 137.","journal-title":"Cell Death Dis"},{"key":"ref210","doi-asserted-by":"publisher","first-page":"113864","DOI":"10.1016\/j.yexcr.2023.113864","article-title":"Deubiquitinating enzyme OTUD4 regulates metastasis in triple-negative breast cancer by stabilizing Snail1","volume":"434","author":"Ma","year":"2024","unstructured":"Ma X, Wan R, Wen Y, Liu T, Song Y and Zhu Y. Deubiquitinating enzyme OTUD4 regulates metastasis in triple-negative breast cancer by stabilizing Snail1. Exp Cell Res 2024; 434: 113864.","journal-title":"Exp Cell Res"},{"key":"ref211","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1002\/jcp.31104","article-title":"OTUD4 regulates metastasis and chemoresistance in melanoma by stabilizing Snail1","volume":"238","author":"Gao","year":"2023","unstructured":"Gao Y, Tang J, Ma X, Zhang C, Huang L, Che J, Wen Y, Zhang Y, Zhu Y, Liu T and Zhang H. OTUD4 regulates metastasis and chemoresistance in melanoma by stabilizing Snail1. J Cell Physiol 2023; 238: 2546-2555.","journal-title":"J Cell Physiol"},{"key":"ref212","doi-asserted-by":"publisher","unstructured":"Zhu Y, Banerjee A, Xie P, Ivanov AA, Uddin A, Jiao Q, Chi JJ, Zeng L, Lee JY, Xue Y, Lu X, Cristofanilli M, Gradishar WJ, Henry CJ, Gillespie TW, Bhave MA, Kalinsky K, Fu H, Bahar I, Zhang B and Wan Y. Pharmacological suppression of the OTUD4\/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers. J Clin Invest 2024; 134: e176390.","DOI":"10.1172\/JCI176390"},{"key":"ref213","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41419-024-06569-x","article-title":"OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway","volume":"15","author":"Ci","year":"2024","unstructured":"Ci M, Zhao G, Li C, Liu R, Hu X, Pan J, Shen Y, Zhang G, Li Y, Zhang L, Liang P and Cui H. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway. Cell Death Dis 2024; 15: 179.","journal-title":"Cell Death Dis"},{"key":"ref214","doi-asserted-by":"publisher","first-page":"217232","DOI":"10.1016\/j.canlet.2024.217232","article-title":"The deubiquitinase OTUD5 stabilizes SLC7A11 to promote progression and reduce paclitaxel sensitivity in triple-negative breast cancer","volume":"604","author":"Liu","year":"2024","unstructured":"Liu X, Ma Z, Jing X, Wang G, Zhao L, Zhao X and Zhang Y. The deubiquitinase OTUD5 stabilizes SLC7A11 to promote progression and reduce paclitaxel sensitivity in triple-negative breast cancer. Cancer Lett 2024; 604: 217232.","journal-title":"Cancer Lett"},{"key":"ref215","doi-asserted-by":"publisher","unstructured":"Zhang J, Tian T, Li X, Xu K, Lu Y, Li X, Zhao X, Cui Z, Wang Z, Zhou Y, Xu Y, Li H, Zhang Y, Du Y, Lv L and Xu Y. p53 inhibits OTUD5 transcription to promote GPX4 degradation and induce ferroptosis in gastric cancer. Clin Transl Med 2025; 15: e70271.","DOI":"10.1002\/ctm2.70271"},{"key":"ref216","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41392-023-01545-x","article-title":"A20 promotes colorectal cancer immune evasion by upregulating STC1 expression to block “eat-me” signal","volume":"8","author":"Luo","year":"2023","unstructured":"Luo M, Wang X, Wu S, Yang C, Su Q, Huang L, Fu K, An S, Xie F, To KKW, Wang F and Fu L. A20 promotes colorectal cancer immune evasion by upregulating STC1 expression to block “eat-me” signal. Signal Transduct Target Ther 2023; 8: 312.","journal-title":"Signal Transduct Target Ther"},{"key":"ref217","doi-asserted-by":"publisher","first-page":"152471","DOI":"10.1016\/j.prp.2019.152471","article-title":"The potential role of TNFAIP3 in malignant transformation of gastric carcinoma","volume":"215","author":"Du","year":"2019","unstructured":"Du B, Liu M, Li C, Geng X, Zhang X, Ning D and Liu M. The potential role of TNFAIP3 in malignant transformation of gastric carcinoma. Pathol Res Pract 2019; 215: 152471.","journal-title":"Pathol Res Pract"},{"key":"ref218","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00109-020-01902-1","article-title":"The impact of DNA demethylation on the upregulation of the NRN1 and TNFAIP3 genes associated with advanced gastric cancer","volume":"98","author":"Wisnieski","year":"2020","unstructured":"Wisnieski F, Santos LC, Calcagno DQ, Geraldis JC, Gigek CO, Anauate AC, Chen ES, Rasmussen LT, Payão SLM, Artigiani R, Demachki S, Assumpção PP, Lourenço LG, Arasaki CH, Pabinger S, Krainer J, Leal MF, Burbano RR and Arruda Cardoso Smith M. The impact of DNA demethylation on the upregulation of the NRN1 and TNFAIP3 genes associated with advanced gastric cancer. J Mol Med (Berl) 2020; 98: 707-717.","journal-title":"J Mol Med (Berl)"},{"key":"ref219","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cancergen.2015.09.008","article-title":"Evaluation of the germline single nucleotide polymorphism rs583522 in the TNFAIP3 gene as a prognostic marker in esophageal cancer","volume":"208","author":"Ghadban","year":"2015","unstructured":"Ghadban T, Schmidt-Yang M, Uzunoglu FG, Perez DR, El Gammal AT, Miro JT, Wellner U, Pantel K, Izbicki JR and Vashist YK. Evaluation of the germline single nucleotide polymorphism rs583522 in the TNFAIP3 gene as a prognostic marker in esophageal cancer. Cancer Genet 2015; 208: 595-601.","journal-title":"Cancer Genet"},{"key":"ref220","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3892\/ijo.2017.3869","article-title":"TNFAIP3 overexpression is an independent factor for poor survival in esophageal squamous cell carcinoma","volume":"50","author":"Hadisaputri","year":"2017","unstructured":"Hadisaputri YE, Miyazaki T, Yokobori T, Sohda M, Sakai M, Ozawa D, Hara K, Honjo H, Kumakura Y and Kuwano H. TNFAIP3 overexpression is an independent factor for poor survival in esophageal squamous cell carcinoma. Int J Oncol 2017; 50: 1002-1010.","journal-title":"Int J Oncol"},{"key":"ref221","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2018.10.019","article-title":"A20-mediated deubiquitination of ERα in the microenvironment of CD163(+) macrophages sensitizes endometrial cancer cells to estrogen","volume":"442","author":"Lv","year":"2019","unstructured":"Lv Q, Xie L, Cheng Y, Shi Y, Shan W, Ning C, Xie B, Yang B, Luo X, He Q, Zhu Q, Zhang Y, Zhang Z, Wang C, Chen X and Xu C. A20-mediated deubiquitination of ERα in the microenvironment of CD163(+) macrophages sensitizes endometrial cancer cells to estrogen. Cancer Lett 2019; 442: 137-147.","journal-title":"Cancer Lett"},{"key":"ref222","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.mce.2015.12.009","article-title":"TNF alpha signaling is associated with therapeutic responsiveness to vascular disrupting agents in endocrine tumors","volume":"423","author":"Hantel","year":"2016","unstructured":"Hantel C, Ozimek A, Lira R, Ragazzon B, Jäckel C, Frantsev R, Reincke M, Bertherat J, Mussack T and Beuschlein F. TNF alpha signaling is associated with therapeutic responsiveness to vascular disrupting agents in endocrine tumors. Mol Cell Endocrinol 2016; 423: 87-95.","journal-title":"Mol Cell Endocrinol"},{"key":"ref223","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s12013-013-9556-1","article-title":"Bladder polypoid cystitis-derived A20 associates with tumorigenesis","volume":"67","author":"Wang","year":"2013","unstructured":"Wang M and Li S. Bladder polypoid cystitis-derived A20 associates with tumorigenesis. Cell Biochem Biophys 2013; 67: 669-673.","journal-title":"Cell Biochem Biophys"},{"key":"ref224","doi-asserted-by":"publisher","unstructured":"Gong Z, Li A, Ding J, Li Q, Zhang L, Li Y, Meng Z, Chen F, Huang J, Zhou D, Hu R, Ye J, Liu W and You H. OTUD7B Deubiquitinates LSD1 to Govern Its Binding Partner Specificity, Homeostasis, and Breast Cancer Metastasis. Adv Sci (Weinh) 2021; 8: e2004504.","DOI":"10.1002\/advs.202004504"},{"key":"ref225","doi-asserted-by":"publisher","unstructured":"Zhao Y, Ruan J, Li Z, Su X, Chen K, Lin Y, Cai Y, Wang P, Liu B, Schlüter D, Liang G and Wang X. OTUB1 inhibits breast cancer by non-canonically stabilizing CCN6. Clin Transl Med 2023; 13: e1385.","DOI":"10.1002\/ctm2.1385"},{"key":"ref226","doi-asserted-by":"publisher","first-page":"16135","DOI":"10.1074\/jbc.M109.007484","article-title":"OTU Domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) deubiquitinates estrogen receptor (ER) alpha and affects ERalpha transcriptional activity","volume":"284","author":"Stani&#x161","year":"2009","unstructured":"Stanišić V, Malovannaya A, Qin J, Lonard DM and O’Malley BW. OTU Domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) deubiquitinates estrogen receptor (ER) alpha and affects ERalpha transcriptional activity. J Biol Chem 2009; 284: 16135-16145.","journal-title":"J Biol Chem"},{"key":"ref227","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s13402-023-00793-x","article-title":"VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinoma","volume":"46","author":"Zhang","year":"2023","unstructured":"Zhang Q, Li J, Chen Z, Jiang K, Yang K, Huang F, Huang A, Zhang X, Zhang J and Wang H. VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinoma. Cell Oncol (Dordr) 2023; 46: 1001-1014.","journal-title":"Cell Oncol (Dordr)"},{"key":"ref228","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc3582","article-title":"Krüppel-like factors in cancer","volume":"13","author":"MP","year":"2013","unstructured":"Tetreault MP, Yang Y and Katz JP. Krüppel-like factors in cancer. Nat Rev Cancer 2013; 13: 701-713.","journal-title":"Nat Rev Cancer"},{"key":"ref229","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/1759-7714.14320","article-title":"The deubiquitinase OTUD1 inhibits non-small cell lung cancer progression by deubiquitinating and stabilizing KLF4","volume":"13","author":"Ma","year":"2022","unstructured":"Ma X, Wang L, Shi G and Sun S. The deubiquitinase OTUD1 inhibits non-small cell lung cancer progression by deubiquitinating and stabilizing KLF4. Thorac Cancer 2022; 13: 761-770.","journal-title":"Thorac Cancer"},{"key":"ref230","doi-asserted-by":"publisher","first-page":"48","DOI":"10.21037\/sci.2017.05.04","article-title":"Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia","volume":"4","author":"Chen","year":"2017","unstructured":"Chen Y, Pan Y, Guo Y, Zhao W, Ho WT, Wang J, Xu M, Yang FC and Zhao ZJ. Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia. Stem Cell Investig 2017; 4: 48.","journal-title":"Stem Cell Investig"},{"key":"ref231","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.3324\/haematol.2018.191650","article-title":"MDM2- and FLT3-inhibitors in the treatment of FLT3-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin","volume":"103","author":"Seipel","year":"2018","unstructured":"Seipel K, Marques MAT, Sidler C, Mueller BU and Pabst T. MDM2- and FLT3-inhibitors in the treatment of FLT3-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin. Haematologica 2018; 103: 1862-1872.","journal-title":"Haematologica"},{"key":"ref232","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3324\/haematol.2012.062083","article-title":"The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status","volume":"97","author":"Zauli","year":"2012","unstructured":"Zauli G, Celeghini C, Melloni E, Voltan R, Ongari M, Tiribelli M, di Iasio MG, Lanza F and Secchiero P. The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status. Haematologica 2012; 97: 1722-1730.","journal-title":"Haematologica"},{"key":"ref233","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41420-023-01537-4","article-title":"miR-221\/222 induce instability of p53 By downregulating deubiquitinase YOD1 in acute myeloid leukemia","volume":"9","author":"Pei","year":"2023","unstructured":"Pei HZ, Peng Z, Zhuang X, Wang X, Lu B, Guo Y, Zhao Y, Zhang D, Xiao Y, Gao T, Yu L, He C, Wu S, Baek SH, Zhao ZJ, Xu X and Chen Y. miR-221\/222 induce instability of p53 By downregulating deubiquitinase YOD1 in acute myeloid leukemia. Cell Death Discov 2023; 9: 249.","journal-title":"Cell Death Discov"},{"key":"ref234","doi-asserted-by":"publisher","first-page":"114487","DOI":"10.1016\/j.celrep.2024.114487","article-title":"Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib resistance of liver cancer","volume":"43","author":"Dai","year":"2024","unstructured":"Dai H, Wu B, Ge Y, Hao Y, Zhou L, Hong R, Zhang J, Jiang W, Zhang Y, Li H and Zhang L. Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib resistance of liver cancer. Cell Rep 2024; 43: 114487.","journal-title":"Cell Rep"},{"key":"ref235","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.1038\/s41467-021-27348-8","article-title":"Nicotine-mediated OTUD3 downregulation inhibits VEGF-C mRNA decay to promote lymphatic metastasis of human esophageal cancer","volume":"12","author":"Wang","year":"2021","unstructured":"Wang M, Li Y, Xiao Y, Yang M, Chen J, Jian Y, Chen X, Shi D, Chen X, Ouyang Y, Kong L, Huang X, Bai J, Lin C and Song L. Nicotine-mediated OTUD3 downregulation inhibits VEGF-C mRNA decay to promote lymphatic metastasis of human esophageal cancer. Nat Commun 2021; 12: 7006.","journal-title":"Nat Commun"},{"key":"ref236","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12935-019-0816-z","article-title":"OTU deubiquitinase 4 is silenced and radiosensitizes non-small cell lung cancer cells via inhibiting DNA repair","volume":"19","author":"Wu","year":"2019","unstructured":"Wu Z, Qiu M, Guo Y, Zhao J, Liu Z, Wang H, Meng M, Yuan Z and Mi Z. OTU deubiquitinase 4 is silenced and radiosensitizes non-small cell lung cancer cells via inhibiting DNA repair. Cancer Cell Int 2019; 19: 99.","journal-title":"Cancer Cell Int"},{"key":"ref237","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s13046-022-02533-9","article-title":"OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis","volume":"41","author":"Di","year":"2022","unstructured":"Di M, Miao J, Pan Q, Wu Z, Chen B, Wang M, Zhao J, Huang H, Bai J, Wang Q, Tang Y, Li Y, He J, Xiang T, Weng D, Wang L, Xia J and Zhao C. OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis. J Exp Clin Cancer Res 2022; 41: 328.","journal-title":"J Exp Clin Cancer Res"},{"key":"ref238","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s10495-024-01953-6","article-title":"Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells","volume":"29","author":"Li","year":"2024","unstructured":"Li Z, Tian Y, Zong H, Wang X, Li D, Keranmu A, Xin S, Ye B, Bai R, Chen W, Yang G, Ye L and Wang S. Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells. Apoptosis 2024; 29: 1051-1069.","journal-title":"Apoptosis"},{"key":"ref239","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/cbdd.13688","article-title":"OTU deubiquitinase 5 inhibits the progression of non-small cell lung cancer via regulating p53 and PDCD5","volume":"96","author":"Kang","year":"2020","unstructured":"Kang XY, Zhang J, Tang L, Huang L, Tong J and Fu Q. OTU deubiquitinase 5 inhibits the progression of non-small cell lung cancer via regulating p53 and PDCD5. Chem Biol Drug Des 2020; 96: 790-800.","journal-title":"Chem Biol Drug Des"},{"key":"ref240","doi-asserted-by":"publisher","first-page":"30388","DOI":"10.1074\/jbc.M203344200","article-title":"A molecular basis for stabilization of the von Hippel-Lindau (VHL) tumor suppressor protein by components of the VHL ubiquitin ligase","volume":"277","author":"Kamura","year":"2002","unstructured":"Kamura T, Brower CS, Conaway RC and Conaway JW. A molecular basis for stabilization of the von Hippel-Lindau (VHL) tumor suppressor protein by components of the VHL ubiquitin ligase. J Biol Chem 2002; 277: 30388-30393.","journal-title":"J Biol Chem"},{"key":"ref241","doi-asserted-by":"publisher","unstructured":"Breitenecker K, Homolya M, Luca AC, Lang V, Trenk C, Petroczi G, Mohrherr J, Horvath J, Moritsch S, Haas L, Kurnaeva M, Eferl R, Stoiber D, Moriggl R, Bilban M, Obenauf AC, Ferran C, Dome B, Laszlo V, Győrffy B, Dezso K, Moldvay J, Casanova E and Moll HP. Down-regulation of A20 promotes immune escape of lung adenocarcinomas. Sci Transl Med 2021; 13: eabc3911.","DOI":"10.1126\/scitranslmed.abc3911"},{"key":"ref242","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12943-015-0454-6","article-title":"A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression","volume":"14","author":"Chen","year":"2015","unstructured":"Chen H, Hu L, Luo Z, Zhang J, Zhang C, Qiu B, Dong L, Tan Y, Ding J, Tang S, Shen F, Li Z and Wang H. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression. Mol Cancer 2015; 14: 186.","journal-title":"Mol Cancer"},{"key":"ref243","doi-asserted-by":"publisher","unstructured":"Catrysse L, Farhang Ghahremani M, Vereecke L, Youssef SA, Mc Guire C, Sze M, Weber A, Heikenwalder M, de Bruin A, Beyaert R and van Loo G. A20 prevents chronic liver inflammation and cancer by protecting hepatocytes from death. Cell Death Dis 2016; 7: e2250.","DOI":"10.1038\/cddis.2016.154"},{"key":"ref244","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41419-020-2278-6","article-title":"A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma","volume":"11","author":"Feng","year":"2020","unstructured":"Feng Y, Zhang Y, Cai Y, Liu R, Lu M, Li T, Fu Y, Guo M, Huang H, Ou Y and Chen Y. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma. Cell Death Dis 2020; 11: 89.","journal-title":"Cell Death Dis"},{"key":"ref245","doi-asserted-by":"publisher","first-page":"13645","DOI":"10.1021\/acs.jmedchem.2c00408","article-title":"Discovery of Potent OTUB1\/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer","volume":"65","author":"Tan","year":"2022","unstructured":"Tan L, Shan H, Han C, Zhang Z, Shen J, Zhang X, Xiang H, Lu K, Qi C, Li Y, Zhuang G, Chen G and Tan L. Discovery of Potent OTUB1\/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer. J Med Chem 2022; 65: 13645-13659.","journal-title":"J Med Chem"},{"key":"ref246","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1021\/acschembio.3c00227","article-title":"Cellular validation of a chemically improved inhibitor identifies monoubiquitination on OTUB2","volume":"18","author":"Gan","year":"2023","unstructured":"Gan J, de Vries J, Akkermans JJLL, Mohammed Y, Tjokrodirijo RTN, de Ru AH, Kim RQ, Vargas DA, Pol V, Fasan R, van Veelen PA, Neefjes J, van Dam H, Ovaa H, Sapmaz A and Geurink PP. Cellular validation of a chemically improved inhibitor identifies monoubiquitination on OTUB2. ACS Chem Biol 2023; 18: 2003-2013.","journal-title":"ACS Chem Biol"},{"key":"ref247","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41419-023-05900-2","article-title":"Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer","volume":"14","author":"Zhang","year":"2023","unstructured":"Zhang Y, Du T, Liu N, Wang J, Zhang L, Cui CP, Li C, Zhang X, Wu B, Zhang J, Jiang W, Zhang Y, Zhang Y, Li H and Li P. Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer. Cell Death Dis 2023; 14: 378.","journal-title":"Cell Death Dis"},{"key":"ref248","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12964-024-01519-8","article-title":"Rolapitant treats lung cancer by targeting deubiquitinase OTUD3","volume":"22","author":"Du","year":"2024","unstructured":"Du T, Gu Q, Zhang Y, Gan Y, Liang R, Yang W, Lu Y, Xu C, Wu J, Ma R, Cao H, Jiang J, Wang J and Feng J. Rolapitant treats lung cancer by targeting deubiquitinase OTUD3. Cell Commun Signal 2024; 22: 195.","journal-title":"Cell Commun Signal"},{"key":"ref249","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41419-024-06941-x","article-title":"Rupatadine-inhibited OTUD3 promotes DLBCL progression and immune evasion through deubiquitinating MYL12A and PD-L1","volume":"15","author":"Sui","year":"2024","unstructured":"Sui Y, Shen Z, Li X, Lu Y, Feng S, Ma R, Wu J, Jing C, Wang Z, Feng J and Cao H. Rupatadine-inhibited OTUD3 promotes DLBCL progression and immune evasion through deubiquitinating MYL12A and PD-L1. Cell Death Dis 2024; 15: 561.","journal-title":"Cell Death Dis"},{"key":"ref250","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/cancers15020517","article-title":"AtomNet-Aided OTUD7B inhibitor discovery and validation","volume":"15","author":"Chen","year":"2023","unstructured":"Chen J, Bolhuis DL, Laggner C, Kong D, Yu L, Wang X, Emanuele MJ, Brown NG and Liu P. AtomNet-Aided OTUD7B inhibitor discovery and validation. Cancers (Basel) 2023; 15: 517.","journal-title":"Cancers (Basel)"},{"key":"ref251","doi-asserted-by":"publisher","unstructured":"Pan T, Hua MH and Lv N. NSC1122002, a TRAF-binding domain inhibitor, inhibits collagen-induced arthritis in a mouse model. Clin Exp Rheumatol 2022; 40: 1718-1725.","DOI":"10.55563\/clinexprheumatol\/165lpx"},{"key":"ref252","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nchembio.1455","article-title":"A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses","volume":"10","author":"Liang","year":"2014","unstructured":"Liang Q, Dexheimer TS, Zhang P, Rosenthal AS, Villamil MA, You C, Zhang Q, Chen J, Ott CA, Sun H, Luci DK, Yuan B, Simeonov A, Jadhav A, Xiao H, Wang Y, Maloney DJ and Zhuang Z. A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses. Nat Chem Biol 2014; 10: 298-304.","journal-title":"Nat Chem Biol"},{"key":"ref253","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ccr.2012.08.007","article-title":"A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance","volume":"22","author":"Chauhan","year":"2012","unstructured":"Chauhan D, Tian Z, Nicholson B, Kumar KG, Zhou B, Carrasco R, McDermott JL, Leach CA, Fulcinniti M, Kodrasov MP, Weinstock J, Kingsbury WD, Hideshima T, Shah PK, Minvielle S, Altun M, Kessler BM, Orlowski R, Richardson P, Munshi N and Anderson KC. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 2012; 22: 345-358.","journal-title":"Cancer Cell"},{"key":"ref254","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating enzymes and drug discovery: emerging opportunities","volume":"17","author":"Harrigan","year":"2018","unstructured":"Harrigan JA, Jacq X, Martin NM and Jackson SP. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov 2018; 17: 57-78.","journal-title":"Nat Rev Drug Discov"},{"key":"ref255","doi-asserted-by":"publisher","first-page":"117334","DOI":"10.1016\/j.ejmech.2025.117334","article-title":"Structural requirements of isoform-specific inhibitors of Akt: Implications in the development of effective cancer treatment strategies","volume":"287","author":"Adon","year":"2025","unstructured":"Adon T, Bhattacharya S, Madhunapantula SV and Kumar HY. Structural requirements of isoform-specific inhibitors of Akt: Implications in the development of effective cancer treatment strategies. Eur J Med Chem 2025; 287: 117334.","journal-title":"Eur J Med Chem"},{"key":"ref256","doi-asserted-by":"publisher","unstructured":"Zhang Z, Huang D, Feng J, Li W, Wang Z, Lu M, Luo Y, Yang W, Xu Z, Xie Q, Ding W, Tan X, He W, Li G, Liu H and Lei S. PDE5 inhibitors against cancer via mediating immune cells in tumor microenvironment: AI-based approach for future drug repurposing exploration. J Interdisciplinary Medicine 2024; 2: e20230062.","DOI":"10.1002\/INMD.20230062"},{"key":"ref257","doi-asserted-by":"publisher","first-page":"20230025","DOI":"10.1002\/INMD.20230025","article-title":"Anti-angiogenic therapy enhances cancer immunotherapy: mechanism and clinical application","volume":"2","author":"AQ","year":"2024","unstructured":"Li AQ and Fang JH. Anti-angiogenic therapy enhances cancer immunotherapy: mechanism and clinical application. J Interdisciplinary Medicine 2024; 2: 20230025.","journal-title":"J Interdisciplinary Medicine"},{"key":"ref258","doi-asserted-by":"publisher","first-page":"14742","DOI":"10.18632\/oncotarget.7521","article-title":"A20 inhibits the motility of HCC cells induced by TNF-α","volume":"7","author":"Wang","year":"2016","unstructured":"Wang X, Ma C, Zong Z, Xiao Y, Li N, Guo C, Zhang L and Shi Y. A20 inhibits the motility of HCC cells induced by TNF-α. Oncotarget 2016; 7: 14742-14754.","journal-title":"Oncotarget"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/11\/ajcr0167081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:48:14Z","timestamp":1768963694000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/11\/ajcr0167081.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":259,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/jiar9649","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}